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ABSTRACT 
 
The objective of my PhD study was to develop and characterize new methods and 
sensors based on fluorescence resonance energy transfer (FRET) for bioanalysis.  
Chapter 3 describes the use of FRET between donor fluorophores and acceptor labeled 
murine macrophage cells. FRET microscopy was used to determine whether the donor 
molecules truly permeate through the cell membrane or only adsorb to the cell surface. 
This method was found to be partially successful since the donor red tail fluorescence 
overlapped with the sensitized acceptor fluorescence and led to false reading of FRET.  
We found that is easier to monitor delivery of acceptor molecules into donor-labeled 
cells. Using donor labeled cells it was possible to determine whether the acceptor 
molecules were actually delivered into cells. However, a relatively high acceptor 
concentration in the hundreds of micromolar level was needed to obtain measurable 
FRET signals in the 3-D cellular system. The results underscored the need to reduce 
the dimensionality of FRET systems in order to increase the FRET efficiency between 
donor and acceptor molecules.  
Chapter 4 describes the development of FRET sensing lipobeads labeled with donors 
and their use to evaluate the interactions of acceptor molecules with the phospholipid 
membrane of FRET sensing lipobeads. The change in the dimensionality of the system 
in which FRET occurs, improved the sensitivity of our measurements by 3-folds 
compared to FRET measurements in solution. We concluded that a molecular 
recognition component had to be added to the sensing particles to further increase their 
selectivity and sensitivity. 
 xv 
 
Chapter 5 describes the development of FRET trap sensing beads and their use for 
screening nonfluorescent carbohydrates and glycoproteins. The FRET sensing 
technique was based on binding between dextran molecules labeled with Texas Red 
(Dextran-TR) and polystyrene microparticles labeled with Fluorescein tagged 
Concanavalin A (FITC-ConA). It was found that carbohydrates and glycoproteins inhibit 
the binding between dextran-TR and FITC-ConA labeled particles. The inhibition effect 
was concentration dependent thus enabled screening carbohydrates and glycoproteins 
based on their inhibition potency. The dissertation critically evaluates the performance 
of FRET microscopy and FRET based sensors in delivery and screening applications. 
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CHAPTER 1 
BACKGROUND OF FRET BASED SENSORS 
 
Fluorescence based sensors and biosensors have been valuable analytical tools since 
fluorescence is a highly sensitive and selective phenomenon [1, 2]. Recent 
developments in the field of biosensors enabled their employment in new applications 
primarily focusing on real time monitoring of biomolecular interactions. For example, 
biosensors were used to monitor processes like ligand fishing [3], signal transduction in 
cells [4, 5], cell adhesion [6], enzymatic reactions [7], and protein conformation changes 
and aggregation [8, 9]. Fluorescence based biosensors have also been employed in the 
drug discovery in studies involving primary screening of drug candidates as well as 
clinical trials [10-13]. Fluorescence biosensors demonstrate significant advantages over 
commonly used electrochemical sensing techniques since they do not consume their 
targeted analyte. Several problems of current fluorescence sensors include instabilities 
due to high photobleaching rates of sensing fluorophores and leakage of fluorophores 
from the sensing support. Other environmental parameters such as pH, polarity and 
temperature also affect the analytical properties of fluorescence sensors. Most currently 
used fluorescence sensors are based on a direct interaction of the sensing fluorophores 
with their targeted analyte. Unfortunately there is a limited number of analytes (pH, 
oxygen, calcium) that interact directly with fluorophores. Therefore there is a clear need 
for the development of new  sensing techniques to expand the scope of analytes that 
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coud be detected with sensors. Fluorescence resonance energy transfer (FRET) could 
be used to detect analytes previously inaccessible to fluorescence sensing technology. 
Since FRET depends highly on the distance between donor and acceptor molecules, 
FRET based sensors could also provide valuable information about systems involving 
ligand-receptor binding or interactions between fluorescent drugs and acceptor labeled 
cells. Furthermore, FRET based sensors are less affected by environmental and 
illumination factors and therefore offer improvement in analytical performance compared 
to fluorescence intensity-based sensors. Several sections are presented in this chapter 
to explain fluorescence and fluorescence sensing techniques. These include 
fluorescence microscopy, the principles of fluorescence energy transfer (FRET) and the 
parameters affecting the energy transfer efficiency.  
 
 
1.1. Fluorescence and Fluorophores 
Luminescence is the emission of light from electronically excited states of materials. 
Luminescence is divided formally into fluorescence and phosphorescence, based upon 
the nature of the excited state. Fluorescence is the emission of light from a singlet state, 
when the electrons are paired. The lifetime of fluorescence is generally in the range of 
10-8 sec. Phosphorescence is the emission of light from a triplet-excited state, when the 
electrons are unpaired. Phosphorescence lifetimes are longer than fluorescence 
lifetimes and range between 10-3 and 1sec. The phosphorescence transition from the 
triplet excited state to the ground state is forbidden since the electrons in the ground 
and excited states have different spin orientations [14-15]. 
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Fluorescence occurs typically in aromatic substances that show molecular planarity and 
orbitals with delocalizated electrons over multiple conjugated double bounds. Recently, 
hundreds of fluorescent molecules (fluorophores) have been discovered and used in 
different applications [16-19]. Fluorophores are categorized as intensity-based sensing 
probes and wavelength-ratiometric probes. Intensity-based probes are fluorophores that 
display changes in emission intensity but do not display spectral shifts. The changes in 
the fluorescence intensity are typically due to different quantum yields of the free and 
complexed forms, rather than differences in the absorption spectrum. Considering a 
fluorescent probe, F, which reacts with an analyte, A: 
A+ F →AF          (1.1) 
The analyte concentration [A] is expressed as: 
[A] = KD (F-Fi) / (FF - F)        (1.2) 
where Fi is the fluorescence intensity when the fluorophore is in the free form, FF is the 
fluorescence intensity when the fluorophore is completely reacted with the analyte. F is 
the fluorescence intensity when the indicator is incompletely complexed by the analyte 
A. KD is the dissociation constant of the complex formed between the analyte and the 
fluorescent probe.  
The relation (1.2) shows the major limitation of the intensity-based probes. The range of 
analyte concentrations that could be detected by these probes is limited to 0.1 
KD<[A]<10KD. Concentrations lower than 0.1 KD or higher than 10KD will produce little 
change in the observed signal. Wavelength-ratiometric probes have spectral shifts in 
their excitation or emission spectra when binding analytes. The analyte concentrations 
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are determined from the ratio of emission or excitation intensities, independent of the 
overall probe concentration. Using wavelength-radiometric probes the fluorescence 
measurements are independent of the fluorophore concentration, in contrast to 
intensity-based measurements. 
 
Fluorescein, Sulforhodamine B and Texas Red are commonly used green and red 
fluorophores. Their inherent emission properties make them suitable for a broad 
spectrum of applications [20-25]. The structures of these fluorophores are shown in 
figure 1.1 [26]. These fluorescent dyes and their derivatives were frequently used in our 
experiments since they are characterized by large emission quantum yields and 
spectral Stoke shifts. Fluorescein is a pH sensitive dye, presenting several ionic forms 
[14, 26]. The changes in the absorption and emission spectra represent shifts in the 
equilibrium between the two fluorescent anions, the mono and dianion forms. These 
changes in the emission and excitation spectra could be used for wavelength-
ratiometric pH measurements. However, due to its anionic charges at physiological pH, 
Fluorescein does not permeate with high yield into living cells. In order to overcome this 
limitation and to minimize the background fluorescence of fluorophores located outside 
the cells, nonfluorescent cell permeable derivatives of Fluorescein were recently 
developed. Fluorescein Diacetate and Calcein Acetoxymethyl (Calcein AM) (figure 1.2) 
are two examples of nonfluorescent molecules that permeate freely through cell 
membranes. These molecules become fluorescent after the cleavage of the ester bonds 
by nonspecific cellular esterases. Calcein AM is less prone to leakage outside the 
cellular cytoplasm since it bears more charged residues than Fluorescein Diacetate.  
 5
 
 
 
 
 
 
 
 
   
 
 
a)         b)  
c)  
Figure 1.1. Structures of a) Fluorescein, b) Sulforhodamine B and c)Texas Red. 
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Sulforhodamine and Texas Red (figure 1.1) are long wavelength excitable dyes with 
excitation wavelengths: 565 nm and 610 nm respectively. These red dyes are 
insensitive to pH changes and less prone to bleaching compared to Fluorescein dyes, 
making them more suitable for a broader range of applications. Cell Tracker Orange, a 
derivative of Tetramethylrhodamine is used mainly as a probe for long-term cell labeling 
since it undergoes glutathione S-transferase mediated reactions in the cellular milieu 
[26]. Rhodamine and Texas Red cell permeable derivatives were used for long term 
cellular studies such as quantifying cellular thiol levels [27], cell viability, cell fusion 
[28,29] and transplantation [30]. The use of these red dyes minimizes the effect of cell 
autofluorescence on the measurements. 
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a)  
          
b)  
 
 
 
 
 
c)  
Figure 1.2. Structures of a) Fluorescein Diacetate, b) Cell Tracker Orange and c) 
Calcein Acetoxymethyl (Calcein AM).  
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1.1. 1. Jablonski Diagram 
The process of fluorescence, especially for organic molecules, is explained by the 
Jablonski diagram [14]. A typical Jablonski diagram is illustrated in figure 1.3. The 
singlet ground state, S0, the first, S1 and the second, S2, electronic excited states are 
depicted. The vibrational energy levels are denoted by 0,1,2, etc. The absorption of 
photons typically occurs from the lowest vibrational level of S0 to a vibrational state of S1 
or S2. After the light was absorbed by the fluorophore several processes take place. 
Molecules rapidly relax to the lowest vibrational level of S1 through a process called 
internal conversion. This process occurs within 10-12 sec. Fluorescence emission starts 
from a thermally equilibrated state, the lowest vibrational level of the excited state, S1, 
and ends at a higher vibrational state of the ground-state level, S0, which subsequently 
reaches quickly thermal equilibrium. The fluorescence lifetime of S1 is generally in the 
range of 10 -8 sec. The consequence of the emission to the high vibrational level of S0 is 
that the fluorescence emission is the mirror image of the absorption spectrum of the 
S0→S1. In fact, the similarity of the emission and absorption spectra of a molecule 
proves that the electronic excitation required for a molecule to fluoresce does not alter 
the nuclear geometry (Frank-Condon principle). Due to the energy loss within the 
excited state, the energy of the emitted photons is lower than the absorption energy. 
Consequently, the wavelength of the emitted photons is longer than the wavelength of 
the excitation photons. The difference between the fluorescence wavelength and the 
absorption wavelength is defined as the Stokes shift. A larger Stokes shift increases the 
sensitivity of fluorescence measurements as it allows emission photons to be detected 
against a lower background, better spectrally separated from the excitation photons. 
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Figure1.3. Jablonski diagram describing radiative and nonradiative transitions in 
molecular systems.  
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In some special cases, molecules in S1 could undergo another transition to a triplet 
state, T1.  Emission of photons from the triplet state, T1, is named phosphorescence and 
is shifted to lower energies (longer wavelengths) compared to fluorescence. The 
transition from the excited triplet state, T1, to the ground level, S0, is forbidden, thus the 
phosphorescence lifetimes are several orders of magnitude longer than fluorescence 
lifetimes. Heavy atoms, like bromine and iodine increase the rate of intercrossing 
system from S1 to T1, thus increase the phosphorescence quantum yield. Three 
significant nonradiative deactivation processes are associated with fluorescence: 
internal conversion, intersystem crossing and vibrational relaxation. Internal conversion 
is the radiationless transition between energy states of the same spin state. Intersystem 
crossing is a radiationless transition between different spin states. Vibrational relaxation 
of the fluorophores takes place very quickly (<1 x 10-12 sec) and quenches the 
fluorescence emission. Vibrational relaxation occurs due to collisions between excited 
molecules and quenchers, while the fluorophore is in the ground or excited states. 
  
1.1.2. Characteristics of Fluorescence Emission 
Fluorescence is a cyclical process; a fluorescent molecule can be repetitively excited 
and detected. Since a single fluorophore generates thousands of photons the sensitivity 
of fluorescence-based methods is higher than the sensitivity of absorption methods. 
Recently, fluorescence techniques made possible the detection of single molecules and 
single molecule events. Unfortunately, fluorescent molecules are characterized by high 
rate of photobleaching. Photobleaching results in a loss of fluorescence due to the 
destruction of the fluorophore by irradiation. The mechanism of photobleaching is not 
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well understood. It often involves a reaction of excited fluorophores with singlet oxygen 
that leads to decomposition of fluorophores [14].   
Generally, fluorescence molecules display a number of common characteristics that 
enable differentiation between fluorescence and scattering phenomena (Raman, 
Raleigh):  
- Emission occurs at longer wavelengths than the absorption wavelength (Stokes’ 
Shift). 
- Emission spectra are independent of the excitation wavelength. 
- Quantum yields are generally independent of the excitation wavelength. 
 
Fluorescence Lifetime and Quantum Yield 
The most important characteristics of fluorophores are their quantum yield (Q) and 
fluorescence lifetime (τ). The quantum yield, Q, is defined as the ratio between the 
number of emitted photons and the number of absorbed photons [14]. Emission 
quantum yields approache unity for substances with the brightest emission. For 
example, Fluorescein derivatives have quantum yield close to unity. Emission quantum 
yields are expressed as: 
Q =
nrk+Γ
Γ
           (1.3) 
where: Γ - emissive rate of the fluorophore 
nrk - rate of nonradiative decay to S0. 
The fluorophore excited lifetime (τ) determines the extent in which the excited 
molecules could interact with their environment. In general, fluorescence lifetimes range 
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between 10 nsec and 10µsec. The fluorescence lifetime is given by the following 
equation. 
τ =
nrk+Γ
1
           (1.4) 
In fact only a few molecules would emit exactly at t =τ. Thus, the fluorescence lifetime is 
only an average value representing the average lifetime of an ensamble of fluorophores. 
The quantum yield of fluorophores affects the sensitivity of the fluorescence 
measurement. A bright fluorophore, with a large quantum yield would increase the 
sensitivity of the measurement while minimizing the required probe amount. 
 
 
1.2. Fluorescence Sensors 
A chemical sensor is a device or instrument that determines the detectable presence or 
concentration of a given analyte. The chemical interaction between the analyte and the 
sensor occurs at the solid interface. A transducer transforms the analyte-sensor 
interaction into a continuous optical or electrical signal, which is proportional to the 
analyte concentration. If the sensor contains a biological sensing element that interacts 
specifically with the analyte, the sensor is called a biosensor. The choice of an 
appropriate transducer for a given analyte depends on the desirable analytical 
properties such as the detection limit, precision, reproducibility and cost of the sensor. 
The sensitivity and selectivity of biosensors depend not only on the analyte binding 
affinity and specificity towards the biological recognition element but also on the 
transducer performance [31, 32]. Traditionally, biological sensing elements are based 
on catalytic properties of enzymes, microorganisms, and tissues or on the molecular 
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recognition reactions of antibodies, nucleic acids, lectins and receptor proteins. 
Recently G-protein-coupled receptor ligands (GPCRs) were extensively used in 
combination with fluorescence based sensors to screen potential drugs. These 
receptors mediate the cellular response to hormones and neurotransmitters. Numerous 
diseases are related to mutations in GPCRs structure [33]. 
 
A fluorescence based bio/chemical sensor designed for intracellular analysis must be 
highly compatible with the cellular environment, have low cytotoxicity, and high chemical 
stability and photostability.  In order to prevent cytotoxicity upon insertion of the sensor 
into the cell, the fluorophore should be isolated from the cellular milieu by a compatible 
matrix. In our laboratory we improved the compatibility of miniaturized fluorescence 
sensors by  using a phospholipid layer to coat the surface of the sensor [34, 35]. 
Fluorescence analogs of drugs have been used to investigate the delivery properties of 
various drug formulations into single cells [36, 37]. There are several problems 
associated with this technique. These include toxicity associated with the excessive 
fluorescent probe loading, possible interference reactions and lack of site specific 
information. In addition, when using classical fluorescence microscopy techniques it is 
difficult to distinguish between molecules absorbed on the surface of cells and 
molecules located inside the cytoplasm. Fluorescence resonance energy transfer 
(FRET) is a fluorescence phenomenon that has the advantage of being largely 
dependent on the distance between the donor and acceptor molecules [38]. This 
technique could be used to determine whether molecules are actually delivered into 
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cells. The proximity between donor labeled cell and an acceptor tagged drug, for 
example, could be evaluated by FRET.  
 
Lately, submicrometric fiber optic sensors were used for site-specific cellular analysis as 
an alternative to free fluorophores [39-41]. Fiber optic sensors are limited to 
measurements in one cell at a time. Recently fabricated fiber sensors arrays improve 
the throughput of fiber optic sensors [42, 43]. However, they are not suitable for single 
cell measurements because of their large size. Even the insertion of a single fiber optic 
sensor into cells may damage the cellular membrane. Fiber optic sensing arrays could 
be used effectively to measure extracellular events. Particle based fluorescence 
sensors have been used as an alternative to fiber optic sensors in cellular analysis [34, 
35]. Advantages of particle based fluorescence sensors compared to microelectrodes 
and fiber optic sensor include better protection against interferences, increased 
simplicity and sensitivity. The sensing fluorescent probe can be immobilized to the 
particle surface through chemical bonding or physical absorption [34, 35] or embedded 
within the particles during polymerization [44]. Polymer particle based sensors proved to 
be an excellent tool for single cell analysis [45, 46]. Particle-based fluorescence sensors 
and biosensors were also used for in vitro screening of potential drugs and provided 
detailed information on drug binding activity to receptors and on binding kinetics (on/off 
reaction rates) [47,48]. Nevertheless, there is a limited number of analytes that can be 
identified and quantified by fluorescence sensors since they are mainly based on direct 
interactions between fluorophores and their targeted analytes. Therefore, there is a 
need to develop new sensors with the capability to detect a wider range of analytes. 
 15
The development of particle-based FRET sensors in this study provided a novel way to 
overcome the lack of site specific information and to expand the range of analytes that 
could be quantified by fluorescence techniques. For example, the FRET based sensors 
described in chapter 5 were used for carbohydrate and glycoprotein screening, 
previously inaccessible to fluorescence sensors. 
 
 
1.2.1 Mechanism of Sensing 
Fluorescence based sensors exhibit changes in fluorescence intensity, wavelength, 
anisotropy and lifetime in the presence of targeted analytes (figure 1.4). Intensity based 
sensors are very practical since the necessary instrumentation is simple, sensitive and 
easily adaptable to various sensor configurations.  
 
1.2.1.1 Fluorescence Quenching  
Fluorescence quenching is a process that reduces the intensity of the fluorescence 
without changing the fluorophore emission spectrum. The decrease in the fluorescence 
intensity is proportional to the quencher concentration. The quenchers are molecules 
that interact with the fluorescent probe. There are several types of fluorescence 
quenching phenomena: collisional, dynamic and self quenching. Collisional quenching 
is often used in fluorescence sensing. The collisions between the analyte-quencher and 
the sensing fluorophore result in a decrease of the sensor fluorescence. When 
quenching occurs by a dynamic mechanism, the excited state is depopulated without 
allowing normal fluorescence emission. A decrease in the fluorescence lifetime 
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accompanies the decrease in the fluorescence intensity of the fluorophore. The 
dependence of the fluorescence of the sensors, F, on the quencher concentration, [Q], 
is given by the Stern-Volmer equation: 
 
][1][1 0
00 QKQk
F
F
q +=+== ττ
τ
        (1.5) 
Where, F0, F and τ0,τ  are the intensities and lifetimes  of the fluorophore in the absence 
and the presence of the quencher, K is the Sterner–Volmer quenching constant and kq 
is the bimolecular quenching constant. 
 
Self-quenching or “concentration quenching” occurs when a fluorophore acts as its own 
quencher. This phenomenon occurs at high concentration of fluorescence dyes. A 
variety of phenomena could contribute to the magnitude of self quenching: radiationless 
transfer of energy between identical molecules (when the Stokes shift is small), 
formation of larger aggregates of dyes or through a Stern-Volmer mechanism in 
solution. Common fluorescent dyes like Fluorescein, Rhodamine and Texas Red and 
their derivatives have a distinct upper concentration limit where self -quenching occurs. 
Fluorescence quenching based sensors were used to determine various analytes like 
oxygen and chloride [14, 34]. It should be noted that a fluorescent probe could be 
quenched not only by the targeted analyte but also by other species like solvent 
molecules or other substances in the sample. The sensor’s response should be 
corrected for these possible interferences. 
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Figure 1.4. Modified Jablonski diagram for dynamic quenching and FRET. 
Legend: hν- energy of the absorbed/emitted photons, knr-non radiative decay rate, kq-
bimolecular quenching constant, kT-transfer rate in fluorescence resonance energy 
transfer (FRET) and 
0
AS , 
2
AS - ground and excited singlet states of the acceptor 
molecule. 
 
 
1.2.1.2. Fluorescence Resonance Energy Transfer (FRET) and Inner Filter 
Effects(IFE)  
 
1.2.1.2.1. Fluorescence Resonance Energy Transfer (FRET) 
Fluorescence resonance energy transfer (FRET) is a non-radiative energy transfer from 
the excited state of a donor (D) to an acceptor (A). FRET occurs when the emission 
spectrum of a fluorescent donor overlaps the absorption spectrum of an acceptor (figure 
1.5). As a result, the donor lifetime is shortened and the acceptor fluorescence is 
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sensitized [14, 49-51]. The distance between the donor and acceptor has to be in the 
range of 1-10 nm for FRET to occur. 
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Figure 1.5. A spectral overlap (marked in diagonal lines) between the donor emission 
and the acceptor absorption is required for fluorescence resonance energy transfer 
(FRET) between donor and acceptor fluorophores. 
 
 
Mechanism of FRET 
The idea of a nonradiative transfer of electronic excited energy was first proposed by J. 
Perrin in 1920. The model proposed by F. Perrin showed that energy could be 
transferred over hundreds or even thousands of angstroms. It was Th. Forester [52, 53] 
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in 1946 that concluded that FRET could occur over distances up to 100Å. Galanin 
advanced the possibility of “inductive resonance” between molecules spaced at such a 
distance [54]. Forster and Galanin observed a nontrivial fluorescence quenching in 
solutions containing millimolar levels of acceptor molecules [52-54]. This nontrivial 
energy transfer could not be explained as occurring due to a trivial reabsorption of 
donor emission by acceptors. At these large concentrations the intermolecular distances 
are about 100Å or less, therefore the results proved that nonradiative transfer is 
possible when the donor and acceptors are within this distance range. 
 
Two mechanisms could account for nonradiative energy transfer inductive resonance 
and exchange interaction. The inductive resonance mechanism is based on 
contributions from Coulomb interactions while the second is based on exchange 
interactions [49]. The exchange interactions are significant only for distances between 
donor and acceptor molecules that are smaller than 10Å. The inductive-resonance 
mechanism is used to describe energy transfer over larger distances. Several 
phenomenological theories were developed to explain FRET. These theories consider 
donor-acceptor relations such as their spatial arrangement and their diffusion kinetics 
providing descriptive models of FRET. These theories also allow comparisons with 
experimental data [55]. For a more detailed consideration, reference [49] should be 
consulted. The dipole-dipole approximation applied by Th. Forster in his inductive-
resonance theory is used exclusively to explain FRET. The essence of this 
approximation is explained below. 
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Inductive-Resonance Theory 
The theory assumes that the donor and the acceptor are placed at a sufficient large 
distance so that their electronic clouds do not interact. Consequently, the electronic 
spectra of the donor and acceptor are not deformed. In order for FRET to occur the 
acceptor must have an absorption band overlapping the donor emission band and a set 
of equal or similar levels of energy. In this case a flow of energy from the donor to the 
acceptor is possible. The phenomenon is equivalent to resonance between two 
mechanical pendulums.  
Forster calculated the energy transfer probability as:  
P= (2π/ħ)|<H>|2 δ          (1.6) 
 
where P is the probability of the nonradiative energy transfer from the donor to the 
acceptor, <H>, is the matrix element of the Hamiltonian for their interaction, and δ is the 
density of states. Assuming that <H> is a sum of Coulomb interactions of external 
electrons of the donor and acceptor, expanded in Taylor series, the Hamiltonian of the 
dipole-dipole interaction can be written as: 
)])((3[ 23
2
RrRr
R
rr
R
eH ADAD −= ε        (1.7) 
where R is a vector connecting the donor and acceptor oscillators, rD and rA are the 
vectors connecting the centers of molecules with the optical electrons, e is the electron 
charge, ε is the dielectric permeability of the medium to the optical frequencies. The rate 
constant of the energy transfer considering the wave function as a product of the 
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electron wavefunction and the vibrational function and normalizing the spectrum of the 
donor can be expressed as: 
∫∞=
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where K2 is the orientation factor, FD(ν) is the spectral distribution of the donor 
fluorescence (normalized to the wavenumbers), εa(ν) is the molar coefficient of the 
acceptor extinction, N is Avogadro’s number, n is the refractive index of the solvent, τ0 is 
the intrinsic lifetime of the donor in the absence of the acceptor, and R is the distance 
between the donor and the acceptor. 
The expression (1.8) was written by Forster in the following reduced form: 
6
01 ⎟⎠
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R
Rkt τ
          (1.9) 
 
where τ is the measured lifetime of the donor in the absence of the acceptor. It is 
related to τ0 via the quantum yield of the fluorescence: 
 
τ= ϕτ0           (1.10) 
The parameter R0 from equation (1.9) is called the Forster distance, the distance at 
which the energy transfer efficiency is 50%. 
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The value of Forster distance, R0, can be calculated by substituting in equation (1.11) 
the values of the spectral parameters obtained from the donor and acceptor. Typically 
the values of the Forester distance range between 20 and 70 Å [14, 50]. 
 
The decay of the donor intensity and the quantum yield were described by Forester for 
a completely homogeneous solution. Forester showed that the efficiency of this process 
(E) is dependent on the sixth power of the distance between the donor and acceptor, 
hence highly sensitive and specific phenomenon to any change that might affect the 
donor or the acceptor. 
66
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For a randomly distributed solution, R0 is expressed as: 
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R π          (1.13)  
where N is Avogadro number and A0 is the concentration of the acceptor at which the 
energy transfer is 76%. Relation (1.13) reveals important feature of energy transfer 
between donors and acceptors. For a system of randomly distributed donors and 
acceptors, the concentration of the acceptor required for efficient FRET is in the 
milimolar range. The high acceptor concentration complicates the FRET measurements 
since inner filter effects (IFE) interfere significantly with FRET. 
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Effect of Orientation Factors 
The orientation factor K2, which defines the relationship between the donor and 
acceptor dipole moments can range between 0 for perpendicular dipole moments and 4 
for parallel dipole moments.  For example K2 is assumed equal to 2/3 for random 
orientations. There are a number of extensive discussions in the literature about the 
effect of different donor and acceptor orientation geometries on the efficiency of the 
energy transfer [56-61]. The orientation factor, K2, is important only when the geometry 
between interacting donor and acceptor molecules is well defined. In most applications 
of FRET, in which the labeling procedure introduce considerable heterogeneity the 
orientation factors are less important [62]. 
 
Effect of System Dimensionality on FRET 
For randomly distributed acceptors, the donor fluorescence decrease depends on the 
dimensionality of the acceptor distribution. Different distribution functions are used when 
the acceptor molecules are dispersed in a volume (three-dimensional or 3D), in a plane 
or along a line. For example, planar distribution is possible when the donor and 
acceptor absorbed into a membrane (two-dimensional or 2D), linear distribution (uni-
dimensional or 1D) could be realized when dyes intercalate into a DNA helix. For a 
random distribution of acceptors and donors (like in solution), assuming no diffusion and 
no excluded volume, the intensity decays of the donors, in the presence of acceptors, 
can be calculated using the following analytical form [63-66]: 
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where d= 3, 2 and 1 for tri-, two- and uni-dimensional distribution, ID is donor decay time 
in the absence of acceptors  and γ is a function related to the concentration of the 
acceptor and the dimensionality of the system. 
 
The extent of energy transfer (equation 1.14) for the same concentration of acceptor 
molecules is higher in uni-dimensional than in three-dimensional system. As described 
in this thesis, this characteristic of energy transfer results in improved sensitivity of 
FRET based sensors compared to FRET measurements in solution.  Although the 
theory of FRET for multiple acceptors, restricted geometries and diffusion of donor –
acceptor is quite complex, FRET is one of few reliable methods for studying the 
proximity and geometric distribution of fluorescent molecules in biological systems. 
However, often unavoidable interfering processes could take place when donor and 
acceptor molecules are present in the same system. Such processes are named inner 
filter effects (IFE). They involve transfer of energy as well. 
 
1.2.1.2.2. Inner Filter Effects (IFE) 
The inner filter effect is a decrease in the fluorescence intensity due to absorption of the 
excitation/ emission light by an absorbing molecule. Inner filter effects are classified as 
a primary inner filter effect when the fluorophore excitation light is absorbed and a 
secondary inner filter effect when the emission of the fluorophore is absorbed by a 
molecule present in the solution.  The theory of inner filter effects in macroscopic 
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samples is well established [67]. Several studies on the theory of IFE in microscopic 
droplet domains were published [68]. The fluorescence intensity ratio of the fluorophore 
prior and following the addition of an absorbing species is expressed as: 
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 for primary IFE and as :       
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for secondary IFE. 
Where  exε  and emε  are the molar absorption coefficients for absorption and emission 
of the absorber, b is the effective pathlength of light and ׀Q׀ is the concentration of the 
absorber/quencher. The fluorescence intensity of the sample in the presence of 
absorber depends not only on the absorber concentration,  ,׀Q׀but  also on the light 
harvesting conditions of the instrumental set-up (slit-width, volume and pathlength of the 
cuvette and wavelength of excitation). IFE based sensors were previously employed for 
the detection of different ions of clinical importance [69, 70]. Unlike FRET based 
sensors, IFE based sensors do not provide site specific information and cannot be used 
to determine donor-acceptor interactions. 
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1.3. Measurements of FRET Efficiency Using Fluorescence Microscopy 
Fluorescence microscopy has enabled the investigations of structure–function 
relationships in living cells.  However, conventional microscopy techniques are limited 
by the light diffraction limit (λ/2), which is about 250 nm. In contrast, FRET microscopy 
could be used to overcome the diffraction limit and to provide information about cellular 
interactions in the nanometer scale [71, 72]. This chapter is reviewing the methods used 
in FRET microscopy for the measurement of energy transfer in solution and cells. The 
theory is adapted mostly from references 73 and 74.  
 
Donor Quenching and Acceptor Sensitized Emission 
Generally, three images are necessary for calculating the efficiency of energy transfer 
between donor and acceptor molecules. I(d/d) is acquired using donor excitation and 
emission filters. I(d,a)  is acquired using donor excitation and acceptor emission filters,  
and I(a/a) is acquired using acceptor excitation and emission filters. These images are 
processed for camera bias, dark current, and inhomogeneities [75, 111]. The 
inhomogeneity conditions result from deviations in the image position introduced by 
differences between dichroic mirrors and emission/excitation filters used to acquire the 
images. It could be corrected by X-Y translations, which are generally less than 10 
pixels. Then, these images are corrected for overlaps between the donor and acceptor 
excitation and emission spectra. The bleed-trough factors could be calculated from 
images of the samples labeled only with donor or acceptor molecules.  
The corrected donor and acceptor emissions can be expressed as [73]: 
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I(d,r) = donor emission, I(d,d), after  image corrections    (1.17) 
I(a,s) = sensitized acceptor emission= I(d,a)-b1I(d,d)-b2 I(a,a)    (1.18) 
In equation (1.18), the first bleed-through factor, b1, describes the donor emission in the 
acceptor channel and the second factor, b2, reflects the direct excitation of the acceptor 
at the donor wavelength used. The final step is to correct I(a,s) with  a factor, ξ, that 
depends on the microscope used for FRET measurements. This factor accounts for the 
differences in absorption, cross-sections, and excitation intensities and detectors 
efficiency. The energy transfer efficiency is calculated for each pixel after the evaluation 
of the bleed-though factor:  E=I(d,t)/I(d,tot)       (1.19) 
where I(d,t)= I(a,s) ξ and I(d,tot)=I(d,r)+I(d,t). I(d,t) is the fluorescence resonance energy 
transferred  from the donor to the acceptor. This method is fairly practical but is 
subjected to cumulative errors associated with the correction factors. Nearly equals 
values are subtracted and divided thus making this method sensitive to small errors in 
the experimental data.  
 
Our Practical Approach for FRET microscopy 
As previously mentioned the analysis of FRET experimental results is prone to artifacts 
and errors. We preferred to evaluate FRET efficiency either from the acceptor 
sensitized emission or from the quenching the donor emission. When acceptor 
sensitized emission was used, the FRET ratio between the fluorescence intensities of 
the acceptor and donor was calculated. The FRET ratio takes advantage of the 
sensitized acceptor emission and the quenching of the donor fluorescence. The two 
effects cause the numerator to increase and the denominator to decrease; therefore the 
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FRET ratio increases as the energy transfer efficiency increases. Unfortunately, 
sometimes the measurement of the acceptor sensitized fluorescence can introduce 
large errors, for example when the signal to noise in the FRET channel is low or 
geometric errors given by the displacement of the filters from different filter 
combinations occur. In the case of the carbohydrate/glycoprotein screening project, the 
augment of the acceptor fluorescence ranged from signal to noise values of 1 to 10. The 
use of FRET ratio could only degrade the quality of the results. Therefore, we used the 
donor quenching method to calculate the FRET efficiency. The excitation wavelength 
was set at the donor absorption and the emission wavelength at the donor emission. 
The donor emission wavelength was selected such that no contribution from the 
acceptor fluorescence was observed.  
  
 
1.4. Carbohydrate Binding Proteins: Lectins. 
Lectins are carbohydrate-binding proteins that bind specifically and reversibly to sugar 
molecules [76-81].  On the basis of their specificity they can be classified into five 
groups according to the monosaccharide, which provides the highest specificity: 
mannose, galactose/ N-acetylgalactosamine, N-acetylneuraminic acid, N-
acetylglucosamine and fucose (sugars are in D configuration, except for fucose that 
appears as L configuration). The interaction of lectins with monosaccharides is usually 
weak with association constants in the range of millimolars [77,80]. Lectins exhibit 
higher specificity for di, tri, and tetrasaccharides with 1000-fold greater association 
constants compared to monosaccharides. Molecular modeling and high resolution NMR 
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measurements have shown that the affinity of lectins to oligosaccharides is affected by 
the shape of the oligosaccharides. Oligosaccharides are flexible molecules due to the 
rotation around the glycosidic bonds that connect the constituent monomers [83-87]. 
The amino-acid sequence and three-dimensional structures of lectins have been 
investigated and elucidated [88-93]. The elucidation of lectin structures enabled the 
classification of lectins based on their common characteristics. The majority of lectins 
are simple, mosaic and organized in macromolecular assemblies.  
 
Lectins from plants, such as Concanavalin A or wheat hemmaglutinin, are the most 
studied carbohydrate binding proteins. They have been used as models for 
understanding the complexity of animal lectins [94,95]. Typically, plant lectins consist of 
two or four identical or almost identical subunits of 25-30kDa, each with a small specific 
binding site for a carbohydrate. Divalent ions, especially Ca 2+ and Mg 2+, are required 
for saccharide binding [96].  The plant lectin subunits are mainly composed of two 
antiparallel β sheets, one of six strands and the other of seven strands. The six-
stranded sheet is almost flat and the other is concave. The concavity of the face 
provides the carbohydrate-binding site, which is easily accessible to monomeric and 
polymeric carbohydrates. The metal ions Ca 2+ and Mg 2+ are in close proximity (9-10 Å) 
to the carbohydrate-binding site. They play a role in positioning the amino acids 
responsible for carbohydrate binding. A correlation between the size of binding loops 
and monosaccharide specificity has been shown [97].  
Many lectins participate in multivalent interactions with oligosaccharides and 
carbohydrate polymers. The apparent affinity binding constants of oligosaccharides to 
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lectins are higher than the binding constants calculated as the oligosaccharides bind to 
a single receptor. Several mechanisms could explain these multivalent interactions: 
chelate effect, subsite binding, steric stabilization, statistical rebinding, and receptor 
clustering [184,186]. 
The recognition sites of lectins are shallow depressions on the surface of the proteins 
[98]. It seems that the recognition sites are preformed since few noticeable 
conformational changes occur due to carbohydrate binding. The main chain positions of 
the amino acids forming the carbohydrate-binding site remain almost rigid prior and 
following sugar complexation. However, the side chains undergo drastic conformational 
changes upon binding [104,105]. The binding sites of the lectins are similar but quite 
different for various lectin families, even if the lectins specificity is the same [103-105]. 
In general, carbohydrate ligands bind only to one of the protein faces [102,105].   
The interactions between carbohydrates and lectins are based on hydrogen bonds and 
hydrophobic effects. The hydrogen bonds are formed between carbohydrate hydroxyl 
groups and amino, hydroxyl and carboxylic groups of the lectins. The metal ion 
coordinations seem to play a role in the saccharide-lectin interactions [101,102]. It is 
also possible that hydrophobic effects exist due to hydrophobic regions of 
carbohydrates and proteins even if the saccharides are highly polar. Water molecules 
sometimes mediate the interaction between the sugar and the protein by water bridges. 
Calorimetric studies of the carbohydrate-protein binding showed that the interactions 
between lectins and carbohydrates are enthalpy driven. The unfavorable loss of entropy 
is compensated by enthalpy gained due to the removal of water molecules bound to 
lectins [103]. 
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CHAPTER 2 
EXPERIMENTAL 
 
 
This chapter describes the experimental methods and instruments used to complete the 
studies performed in this dissertation. Specific technical and experimental details are 
given in the results sections. 
 
2.1. Materials and Reagents 
Microscope glass cover slips used for microscopy and Lab-Tek II chambered 
coverglass were purchased from VWR Corporation. 1,2-Dimyristoyl-sn-glycero-3-
phosphocholine(DMPC),1,2-dimyristoyl-sn-glycero-3-phosphate,1,2dioleoyl-sn-glycero-
3-phosphocholine(DOPC), dioleoyl-sn-phophoethanolanime-N-succinyl(N-succinyl-
DOPE), 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine(PE), and 1,2-
dimyristoyl-sn-glycero-3-phosphate monosodium salt (DMPA)  were purchaesd from 
Avanti Polar Lipids. Cholesterol and dihexadecyl phosphate (DP) were purchased from 
Aldrich. N-(Fluorescein-5-thiocarbomyl)-1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine(Fl-DHPE), carboxyfluorescein, sulforhodamine, dextran-Texas 
Red (dextran-TR, 10000 MW, neutral), Fluorescein diacetate (FDA), Calcein Am (Cal 
Am) and Cell Tracker Orange were obtained from Molecular Probes. Polystyrene 
particles (mean diameter: 1.6 µm, -/+ 0.5%) were purchased from Bangs Laboratories
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, Inc. and Polyscience Inc. Chloroform, methanol, hexane, cholesterol (CH), FITC 
conjugate of concanavalin A (FITC-ConA), concanavalin A type IV, D(+) mannose, 
Ovalbumin (grade V), Glucose-oxidase (245.9 units/g solid), Avidin (10.8 units/mg 
solid), Galactose, Mannose, HEPES buffer, Bovine Serum Albumin (BSA), poly -L- 
lysine, NaCl, CaCl2 and MnCl2 were purchased from Sigma. Sodium hydroxide and 
hexane were purchased from EM Sciences. Spectroscopic grade ethanol was 
purchased from Aldrich. Phosphate buffer (PBS, 100mM, pH=7.4) were obtained from 
Amresco. All aqueous solutions were prepared with 18 MΩ deionized water purification 
system (Barnstead Thermolyne Nanopure). Dulbecco's modified Eagle's medium, L-
glutamine, sodium pyruvate, and fetal bovine serum for the cell culture were purchased 
from Invitrogen.  
 
 
2.2. Instrumental Methods 
2.2.1. Spectrofluorometry Measurements 
A spectrofluoremeter generates the wavelength of light required to excite the sample of 
interest, selects the emitted wavelengths and then measures the intensity of the emitted 
light. A fluorescence spectrum depicting the intensity of emission versus wavelength is 
obtained. The excitation and emission spectra of free dyes, as well as the response of 
fluorescence probes and sensors in solution were acquired using a Photon Technology 
International spectrofluoremeter (QM-1 model, PTI, Ontario, Canada). Each spectrum 
presented in this dissertation is an average of three replicate spectra unless otherwise 
noted.   
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Generally, the excitation wavelength is selected with a narrow bandwidth by the 
excitation monochromator from the light source. Additionally, filters could be used to 
narrow down the excitation light wavelength range. Then, the emitted light reaches the 
sample and excites it. The sample emission is collected and passed through the 
emission monochromator, which separates the wavelength in order to obtain a 
spectrum. The general characteristics of spectrofluoremeter individual components are 
described below. The instrument used in our experiments was equipped with a xenon 
lamp as an excitation light source, two monochromators and a photomultiplier tube 
detector.  
 
2.2.1.2. Light Source 
The PTI spectrofluoremeter is equipped with a 75 W high-pressure xenon (Xe) lamp, 
which is used as the excitation light source. A continuous and homogeneous, intensity 
light output is obtained from 250 nm to 750 nm. Two electrodes are sealed in a glass 
bulb containing Xe under high pressure. When the lamp power is turned on, a high 
voltage discharge occurs between the electrodes and Xe ions are formed. The arc 
lamps emit light continuously as a result of the recombination of electrons with ionized 
Xe atoms. The lamp housing helps to collect the lamp output, which is then focused into 
the entrance slit of the monochromator. The housing also serves to remove excess heat 
and ozone by directing cooled air directly over the lamp. 
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2.2.1.2. Monochromator 
A monochromator is the wavelength selector part of a spectrophotometer. 
Monochromators contain: an entrance slit, a collimating lens, a dispersing device, a 
focusing lens and an exit slit. The dispersing element can be a prism or a grating. The 
polychromatic radiation emitted by the source is directed through the entrance slit and 
collimated by the collimating lens. Then, the light strikes the dispersing element at a 
certain angle and the polychromatic radiation is divided into its component wavelengths 
by dispersion through the prism or the grating. Radiation of only a particular wavelength 
is selected moving the dispersing element in front of the exist slit. The fluoremeter used 
in our studies was equipped with two monochromators; one for excitation and one for 
emission. The monochromators were autocalibrated and under computer control for 
scanning and positioning. 
 
2.2.1.3. Photomultiplier Tube (PMT) Detector 
Photomultiplier tubes (PMTs) are light detectors that convert photons into an electrical 
signal. They have a high internal gain.  Photomultiplier tubes are very sensitive light 
detectors for low intensity applications. A photocathode, a series of dynodes, and an 
anode are placed in evacuated glass tube. The photocathode is made out of an alkali 
metal mixture, which makes the PMTs sensitive to photons in the UV-VIS region of the 
electromagnetic spectrum. The photocathodes operate at a high negative voltage in the 
range of  –500 to –2000 volts. When a photon enters through the glass surface, it hits 
the photocathode which is located on the inner surface of the glass. The photocathode 
hit by the photon ejects a photoelectron due to the photoelectric effect. The electron is 
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attracted and accelerated towards the first dynode. A high voltage charges the dynodes 
positively. After the electron encounters the first dynode, several other photoelectrons 
are emitted. These electrons are subsequently attracted and accelerated to a second 
dynode, which has even higher positive electric potential. The process is repeated 
several times and, 105 to 107 electrons are created for each photoelectron ejected by 
the photocathode. In this way the signal is amplified greatly. The amplification power of 
the PMT depends on the number of dynodes and the accelerating potential difference 
between them. The electrical signal given by the PMT is proportional to the light 
intensity. A vacuum PMT with a wavelength range of 185 to 800 nm was employed as a 
detector in our experiments. 
 
2.2.2. Digital Fluorescence Imaging Microscopy System 
The use of fluorescence microscopy offers many advantages, including specificity, 
sensitivity, quantitative power and high temporal and spatial resolution [107, 108]. Since 
fluorescence is affected by environmental factors, fluorescence microscopy can be used 
to investigate pH, viscosity, refractive index, ionic concentrations, membrane potential, 
and solvent polarity in cells and tissues. Fluorescence measurements of fluorescent 
probes in single cells and of FRET based sensors were performed using an inverted 
epifluorescence microscope (Olympus IX-70). The microscope was equipped with three 
detection ports: one coupled to a spectrograph- CCD camera system, one coupled to a 
CCD camera for imaging, and one coupled to a 35 mm camera.   
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In simple terms, a fluorescence microscope can be described as a conventional light 
microscope with an additional excitation source and an array of filters. The microscope 
is constructed to ensure that the excitation light that passes through the objective has 
an opposite path leading to the eyepiece or detector. The filters and the dichroic mirror 
separate the excitation from the emitted light. The performance of a fluorescence 
microscope depends on the objective and the filters used to obtain the fluorescence 
images. The images obtained with the fluorescence microscope are recorded via a 
storage device such as a camera or a CCD detector. The fluorescence microscope 
individual components are described below. 
 
2.2.2.1. Microscope Objective 
The microscope objective performs two functions: 
• Focus properly the excitation light on the sample. 
• Collect the fluorescence emitted by the sample. 
A microscope in which the excitation and emission light travel through the same 
objective is called epifluorescence [6]. The optics used for the construction of an 
epifluorescence microscope with low noise must separate effectively the emission and 
excitation light pathways. A schematic diagram of an epifluorescence inverted 
fluorescence microscope image is shown in the figure 2.1. The spatial resolution of a 
microscope is defined as the limit for the smallest resolvable distance between two 
points. It is expressed as: 
D=1.22λ/2(NA)          (2.1) 
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where NA is the numerical aperture of the objective lens, NA= n sinα; n is the refractive 
index of the medium next to the lens (e.g. air, water, immersion oil, or glycerol); α is the 
half angle of the cone collected by the aperture of the lens; λ is the wavelength of the 
light used. The optimal resolution is 500-1000 higher than the NA of the objective. 
 
Figure 2.1. Illustration of a typical light path in an inverted epi fluorescence microscope. 
 
Another important parameter of the microscope objective is the light gathering power 
that affects the image brightness. The light gathering power is proportional to the forth 
power of the objective numerical aperture, NA. It should be noted that high 
Sample 
Excitation filter 
Emission filter 
CCD camera 
Microscope objective
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magnification and numerical aperture increase the spatial resolution but also leads to a 
rapid decrease in the sample fluorescence due to photobleaching. 20X and40X 
objectives with a numerical aperture 0.5 or 0.7 respectively were used in our 
experiments. 
 
2.2.2.2. Dichroic Mirror 
The dichroic mirror is used to separate the excitation and emission light paths. In an 
inverted microscope, as used in our experiments, the dichroic mirror position is located 
below the sample. The sample placed on the microscope stage is excited and imaged 
from under the stage. The excitation light is reflected by the surface of the dichroic 
mirror into the objective and used to excite the sample located on the microscope stage. 
The fluorescence light emitted by the sample is collected by the objective and passes 
through the dichroic mirror and through the emission filter to a reflective mirror that 
directs the emitted light to the eyepiece or the detector. Dichroic mirrors are 
characterized by a transition wavelength. The dichroic mirror reflects all light of 
wavelengths lower than the transition value. Light at wavelengths longer than the 
transition value is transmitted through the dichroic mirror. The transition wavelength of 
the dichroic mirror must be chosen between the excitation and emission peak of the 
used fluorophore. 
 
2.2.2.3. Excitation and Emission Filters 
The dichroic mirror is unable to separate completely between the excitation and 
emission light.  About 10 % of excitation light could leak into the detection channel, 
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which could degrade the signal to noise (S/N) ratio in the obtained images. Excitation 
and emission filters are placed in front and below the dichroic mirror in order to improve 
the separation between the excitation and emission lights. Also, the emission filter 
selects the emission wavelength range that reaches the detector. 
 
2.2.2.4. The Filter Cube 
The excitation/emission filters and the dichroic mirror are mounted on an optical holder 
commonly named a filter cube. The cube offers a convenient way to change the dichroic 
mirror and filters as needed for different applications. 
 
2.2.2.5. Light Sources 
Commonly, high-pressure mercury or xenon light sources are used for fluorescence 
microscopy. The lamps are very bright and produce abundant light for majority of 
applications. Sometimes, the illumination is too intense and could cause rapid 
photobleaching of the fluorescence probe or could harm the living organism studied. 
Therefore, neutral density filters are used to minimize the amount of light that the 
specimen encounters. A 100W mercury lamp that consists of two electrodes placed 
under high pressure in a quartz glass tube filled with mercury was used as the light 
source in our studies to evaluate fluorescence probes and the response of FRET 
sensing particles. The mercury lamps do not have even intensity across the 
electromagnetic spectrum. The emission of mercury lamps shows peaks at 313, 334, 
365, 406, 435, 546, and 578 nm. At other wavelengths the emission of the mercury 
lamp is low.  A mercury lamp has a typical lifetime of 200 hours. 
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2.2.2.6. Charged Coupled Device (CCD Camera) 
The most commonly used detectors for fluorescence microscopy are CCD cameras that 
use coupled device (CCD) chip for imaging. CCD chips are silicon-based circuits, which 
are arrays of light sensitive pixels. Electrons are produced by the interaction of photons 
with the silicon atoms of the chip. These electrons accumulate in potential wells and 
then transported across the chip through registers (figure 2.2). The amount of charge 
trapped under each pixel is proportional to the amount of light that falls on it. The 
accumulated charge is then "read out" by changing the electrical bias of an adjacent 
pixel so that the charge moves out of the chip. Then it is converted into a voltage and 
digitized into an intensity value. A two dimensional image is formed by reading the 
charge at each pixel. In a silicon chip, Si atoms are covalently bound to neighboring 
atoms. Energies larger than 1.1 eV are required to break these bonds and create 
electron-hole pairs. Therefore, the shorter the wavelength of the illumination light, the 
shorter the photon absorption depth. There are two types of CCD camera: front and 
back illuminated (figure 2.3). In front-illuminated CCD cameras light enters through the 
CCD gates of the parallel register. The gates are made out of a very thin layer of 
polysilicon, which is relatively transparent at long wavelengths, but becomes opaque at 
wavelengths shorter than 400 nm. Using acid-etching techniques, the silicon can be 
transformed in a 10 µm uniform layer and used to focus an image on the backside of the 
CCD register (figure 2.3). Thinned back-illuminated CCDs exhibit high sensitivity to light 
from the soft X-ray to the near-infrared regions of the spectrum. Coating the CCD chip 
with proprietary phosphor improves the sensitivity of the chips in the ultraviolet region 
(200 nm to 400 nm). 
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Figure. 2.2. Schematic diagram of a CCD pixel. Each pixel in a CCD is a tiny capacitor 
that is formed by growing a layer of silicon dioxide on top of a polysilicon substrate. A 
metal electrode, called gate, is deposited on this structure. 
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Figure 2.3. The geometry of a front and back-illuminated CCD chip.  
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CCD cameras are also classified as: full-frame CCD, interline transfer CCD and frame 
transfer CCD cameras (figure 2.4). Full-frame CCDs are used to obtain high-resolution 
images due to their high-density pixel arrays. The image is collected pixel by pixel. The 
readout is collected by shifting rows of the image in a parallel fashion, one row at a time, 
to a serial shift register. The serial register sends each row of image information to an 
output amplifier as a serial data stream. The read-out charge must be rendered to the 
serial register before the next row of data shifts to the horizontal array. The procedure is 
continued until all rows of data are sent to the output amplifier and to an analog-to-
digital signal converter integrated circuit.  
 
 
Figure 2.4. Schematic diagram of charged coupled device (CCD) cameras: (a) 
conventional full frame CCD with a single parallel register, (b) frame transfer and (c) 
inter-line transfer.  
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The complete pixel array of the camera is used to detect the photons emitted during 
exposure of the specimen. Generally, full frame CCDs has square pixel dimensions to 
avoid image distortions. This kind of camera is  used with a shutter to prevent image 
smearing. Frame-transfer CCDs have a similar design to full-frame CCDs. The biggest 
difference is that these devices have a parallel shift register that is divided into image 
and storage arrays. A new image is collected while a previous one is processed. The 
most important advantage of this type of camera is the capability of frame-transfer 
devices to operate without a shutter, which increases the measurement speed. Interline-
CCDs are hybrid structures incorporating a photodiode into each pixel element and an 
associated parallel readout CCD storage area. These two elements are isolated by a 
metallic mask. As in the case of frame transfer CCDs, interline transfer CCDs can 
function without a shutter. Several frame transfer CCD camera were used in our 
experiments: from Roper Scientific, model EEV with a 512 x1024 pixel array; from 
Andor Technology, model DV434-BV with a 1024x1024 pixel array and from Roper 
Scientific, model 256 HB with a 512x512 pixel array. The Roper Scientific softwares, 
WinSpec 1.4.3 and Winview 3.2, were used for spectral analysis when the spectrograph 
was coupled to the inverted microscope and for image analysis respectively. The Andor 
Technology camera was utilized with the Image ProPlus software, which controlled the 
camera and was also used for image acquisition and analysis. 
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2.2.2.7. Gratings 
A three mirror-spectrograph (Acton Research Inc.) equipped with a 150 and 300 
groves/mm gratings blazed at an optimum wavelength of 500nm was used in our 
experiments. 
 
 
2.3. Protocols and Procedures 
2.3.1. Loading of Donor or Acceptor Dyes into Macrophage Cells 
• Prepare stock solutions of the cell permeable dyes in a range of 1–10 mM. Store 
solutions at -20 ˚C in small aliquots. Take out the medium from the chambered 
coverglass on which murine macrophages cells grew to 70% confluency. Wash 
the cells thoroughly three times with fresh PBS buffer (100mM, pH=7.4).  
• Add 400 µl PBS buffer to each well. 
• Pipette small aliquots of the dye stock solutions until the desired concentration is 
reached. 
• Mix with a Pasteur pipette thoroughly. 
• Incubate 30 min at room temperature or 37 ˚C using an incubator. 
• Wash the cells carefully three times with PBS buffer. 
• Add 400 µl PBS buffer to each well. 
• Pipette small aliquots of the fluorescent and mix cautiously. 
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2.3.2. Preparation of pH Sensitive Sulforhodamine Encapsulating Liposomes 
Prepare a stock solution with 7:1 molar ratio of 1,2 dioleoyl-sn-glycero-3-
phosphocholine(DOPC) and dioleoyl-sn-phophoethanolanime-N-succinyl N-succinyl 
DOPE in chloroform. The overall phospholipid concentration was 250 mg/ml lipid [104].  
2.3.2.1. Injection Method [105] 
•  Dry out a 40 µl aliquot of the phospholipid stock solution under nitrogen flow 
for two hours. 
• Add 40µl dry 2-propanol with rapid vortexing.  
• Inject the alcoholic solution into 1 ml of 5mM Sulforhodamine solution 
dissolved in PBS buffer while vortexing.  
2.3.2.2. Freeze-Thaw Method for pH Sensitive Liposomes 
• Dry out a 40 µl aliquot of the phospholipid stock solution under nitrogen flow for 
two hours  
• Rehydrate the phospholipid film by adding 1ml of 5mM Sulforhodamine solution 
in PBS buffer to form liposomes. 
• Disperse evenly the phospholipids in the working buffer by using a 47 KHz 
Bransonic sonicator bath for 15 minutes. 
• Freeze the liposome solution by placing the vial containing the liposomes in liquid 
nitrogen for 15 minutes.  
• Thaw the sample at room temperature for 15 minutes. 
•  Repeat the freeze-thaw cycle six times.  
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• Separate liposomes containing fluorescent dye from excess dye that is not 
encapsulated inside the liposomes by using a micro-column centrifuge technique 
described below. 
2.3.2.3. Sephadex Column Preparation [105] 
For Sephadex G50: Mix 10 g of G50 resin with 120 ml of distilled water and 0.9 g 
NaCl 
For Sephadex G100: Mix 10 g of G100 resin with 175 ml of distilled water and 
1.575 g NaCl 
• Let the Sephadex solution swell overnight before preparing the Sephadex 
columns for separation. 
•  Fill a 1ml syringe with the Sephadex solution that has its tip blocked with glass 
wool. 
• Centrifuge the syringe in a low-speed centrifuge of 2000 rpm for 5 minutes to 
form a dry solid Sephadex column without cracks or voids. 
•  Add the PBS buffer to the Sephadex containing syringe and centrifuge at the 
same speed as it is used for the sample (see below). 
2.3.2.4. Liposome Separation by Sephadex Column  
Pipette 200 µl liposome solution and centrifuge at 2000 rpm for 15 minutes. 
• Collect the effluent containing the liposomes. 
• The procedure should be repeated until no background from the free dye is seen 
using a fluorescence microscope. 
• Store the liposome solution up to one week at 4˚C. 
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2.3.3. Delivery of Labeled Liposomes into Murine Macrophage Cells 
• Prepare pH sensitive liposomes encapsulating Sulforhodamine with the initial 
dye: lipid ratio= 250:1 and 250 mg/ml phospholipid mixture. Remove out the 
medium from the chambered coverglass in which J 774 murine macrophages 
cells grew until 70% confluency. Wash the cells thoroughly three times with fresh 
PBS buffer (100mM, pH=7.2).  
• Add 400 µl PBS buffer in each well. 
• Pipette different aliquots of the liposome stock solution into each well. 
•  Mix with a Pasteur pipette thoroughly. 
• Incubate cells with liposome solution for 5, 15, 30, 60 minutes. 
 
2.3.4. Maintenance and Preparation of J 774 Murine Macrophage Culture 
Murine macrophage cultures were maintained following a protocol described by Gordon 
et al [106]. The medium used for this culture was Dubelco’s modified Eagles’s medium 
augmented with 4mM L-glutamine, 1.5g/l sodium bicarbonate, 4.5 g/l glucose, 1 mM 
sodium pyruvate, and 10% fetal bovine serum. The culture was grown at 37 0C in a 5% 
CO2 atmosphere. In order to prepare subcultures the cells were scraped, the medium 
was replaced and the cells were splitted into the new vessels. For our experiments, 
cells were plated onto chambered covered glasses, which had been coated with a fetal 
bovine serum for 2 days. Approximately 106 cells/ml were placed on a chambered 
coverglass. Then a 1 ml fresh media was added to the chambers. All chambered 
coverglasses were maintained at 37° C in humidified, 5% CO2 incubator. The 
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macrophages were allowed to attach to the glass for 3 days. Typically, 70 % confluency 
was achieved in three days.  
 
 
2.3.5. Phospholipid Cocktail for Lipobead Coating 
50 mM lipid stock solution prepared with a 5:4:1 molar ratio of DMPC, cholesterol, and 
DP in chloroform, was stored at –200C until used. 
 
2.3.6. Preparation of Lipobeads 
• Weigh 4 mg powder polymeric microspheres and dissolve in 100 µl 1:1 (v/v) 
ethanol/hexane solution. 
• Sonicate for 15 minutes using a 47 KHz Bransonic sonicator. 
• Mix by vortexing 80 µl of phospholipid cocktail solution and 10-50 µl of 5 mM 
labeled phospholipid. 
• Add the phospholipids to the microsphere solution and sonicate for 15 minutes 
using a 47 KHz Bransonic bath sonicator. 
• Incubate the mixture at room temperature for 2 hours. 
• Dry the mixture overnight under nitrogen gas stream. 
• Add 1 ml of phosphate buffer pH 7.0 to the dried bead suspension, and sonicate 
for 15 minutes with a 47 KHz Bransonic sonicator. 
•  Stir magnetically the mixture for 2 hours to allow absorption of phospholipids 
onto the surface of the microspheres. 
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• Wash at least 3 times by slow speed centrifugation of 3000 rpm for 15 minutes to 
remove unbound liposomes and uncoated particles. The lipobeads were 
collected at the bottom of glass centrifuge while the supernatant and unbound 
beads or dye molecules were discarded. 
• Store the lipobead suspension in a glass test tube at 40C up to one week. 
 
2.3.7. HEPES Buffer for Lectin Studies 
The HEPES buffer was composed of: 150 mM NaCl, 1 mM MnCl2, 1 mM CaCl2 and 100 
mM HEPES (pH 7.2). 
 
2.3.8. Preparation of FITC –Con A Coated Beads 
• Weigh 4 mg powder polymeric microspheres. 
• Add 1ml FITC-ConA 200 µg/ml dissolved in HEPES buffer and mix by vortexing. 
• Stir magnetically the mixture for 2 hours to absorb the lectin on the surface of the 
microspheres. 
• Pipette 10 µl 100 mg/ml Bovine Serum Albumine (BSA) and mix well. 
• Incubate for 1 hour while stirring at room temperature. 
• Wash by slow speed centrifugation of 3000 rpm for 15 minutes at least 3 times. 
The FITC-ConA coated lipobeads were collected at the bottom of the glass vial 
while the supernatant is discarded. 
•  Store the FITC-ConA coated beads in a glass vial at 40C up to 3 days. 
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2.3.9. Preparation of poly-L-Lysine Adhesive Slides 
• Wash microscope slide cover-slips with 70% ethanol/water three times. 
• Dry cover-slips at 60 ˚C for 2 minutes in the oven. 
• Pipette poly-L-lysine solution (1ml/ml) on cover-slips. 
• Incubate cover-slips overnight in the dark. 
• Wash cover-slips with working buffer (PBS or HEPES) and incubate them 
with the FRET sensing bead solutions for 4 hours. 
 
 
2.4. Digital Fluorescence Imaging Analysis 
 
The softwares Winview 3.2 of Roper Scientific and Image ProPlus 4.5 of Media 
Cybernetics were used for image analysis. The analysis of the digital fluorescence 
images was carried out either by using automatic features of the software or by 
manually selecting the fluorescent objects. The Image ProPlus software enabled 
analysis of the average fluorescence intensity and size of the observed particles. The 
images features could be enhanced by contrast adjustment and edge emphasis and 
saved in TIFF or GIF standard format in order to be included in this dissertation. The 
contract adjustment of the fluorescence images did not affect the signal to noise ratio of 
the initial images.  
The signal of the sample, Ssample, was computed as an average of the selected object 
intensities (figure 2.5.a and b). The average and the standard deviation were generated 
automatically by the software. For the background calculation 3 different areas were 
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chosen such that the borders of these areas were at least 3 pixels away from the bright 
objects. The average background signal, Sbackground, was calculated manually (figure 
2.5c). The signal to noise of the digital fluorescence images (S/N) was determined as 
following:  
 S/N = (Ssample - Sbackground) / (3 x σbackground)     (2.1.) 
where σbackground is the standard deviation of the background measurements. 
 
 
2.5. Error Analysis 
The error bars of our experiments were calculated from three repeated measurements 
of different particle samples. They represent the fluorescence average signal variation 
in our experiments. The results are presented as +/- standard deviation or errors bars 
from the average fluorescence intensity value. The standard deviation assess how 
broadly the measured values are dispersed from the average value, therefore it is also a 
measure of the reproducibility of our experiments. The standard deviation (SD) was 
calculated using the following standard formula: 
SD=            (2.2.) 
where n is the number of measurements and x represents the value of each 
measurement. 
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a)  
b)  
c)  
Figure 2.5. Digital fluorescence images of FRET sensing beads and their data 
processing: a) initial fluorescence image b) the same image after the selection of the 
desired beads c) and following the selection of the image background.  
 
 
 
  
54
 
Rejection of Gross Errors 
When a set of data contained a result that differed excessively from the average the Q 
test was applied to decide whether to reject or retain the deviating data point. The ratio, 
Qexp, was calculated by dividing the absolute difference, d, between the doubtful result 
and the nearest data point with the spread, w, of the entire set of measurements: Qexp 
=d/w. This ratio was compared with literature values [111]. When Qexp was larger than 
the tabulated values, the questionable result was rejected. A 95% confidence interval 
was used in the rejection of the gross errors. Generally, less than 2% of data were 
rejected performing this test. 
 
Sources of Errors 
Every measurement was effected by many uncertainties, which combine to produce 
scatter results that were characterized by a standard error. For example, fluorescence 
microcopy measurements were affected constantly by about 5% fluctuation in the lamp 
energy output and heterogeneities in the excitation field. Additionally, inconsistencies in 
sample handling were generated by multiple washing steps required to separate particle 
based FRET sensors from their preparation solutions. The reproducibility of the results 
was improved by increasing the number of observed particles in the field of view. For 
our cellular studies, the inability to recognize sub-population of cells also increased the 
error of the measurements. The murine macrophages were a heterogeneous mixture of 
old and young cells, which contributed up to 30% variation in the fluorescence response 
of individual cells.   
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2.6. Methods for Evaluating the FRET Efficiency 
2.6.1. Donor Quenching 
The donor quenching method was often used to calculate the FRET efficiency in our 
experiments. The excitation wavelength is set at donor absorption and the emission 
wavelength at the emission peak of the donor. The donor emission wavelength is 
selected such that minimal contribution from the acceptor fluorescence is allowed. The 
energy transfer efficiency is calculated as: E=1- FDA/FD, where FDA and FD are the 
fluorescence intensities of the donor in presence and absence of acceptor molecules 
[14]. Both fluorescence intensities are normalized to the same donor concentration. 
 
 
2.6.2. Acceptor Enhancement 
This technique is used only when the acceptor molecules fluoresce and can be 
visualized by exciting the sample at the donor absorption wavelength. A sensitization in 
the fluorescence of the acceptor is recorded as the FRET efficiency increases. Since in 
most cases acceptor molecules display some residual absorbance at the excitation 
wavelength of donor, the calculation of the energy transfer efficiency based on the 
sensitized acceptor fluorescence is quite complicated [14]. The FRET efficiency is 
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calculated as: E=1-FA/FAD, where FA and FAD are the fluorescence intensities of the 
acceptor in the absence and presence of the donor.  
 
 
2.6.3. Ratio Imaging 
 
Fluorescence microscopy often suffers from instability in light collection geometry, 
variations in the intensity of excitation at different wavelengths, different photobleaching 
rates and inconsistency in the sample background. These problems could be corrected 
by using ratiometric methods. Ratiometric fluorescence microscopy can be classified 
into several categories according to excitation or/and emission wavelengths used in the 
measurements [73, 109, 110]. The method used in our experiments was emission ratio. 
The sample was excited with a single excitation wavelength, which was the donor peak 
absorption. Then the fluorescence images were collected at two different wavelengths: 
the donor and acceptor peak emission. The ratio between the acceptor and donor 
intensities was calculated from the collected images or spectra. The ratiometric method 
was mainly used for the FRET microscopy studies in cells. The energy transfer 
efficiency was proportional to the ratio of the sensitized acceptor fluorescence and 
quenched donor emission (FA/FD). This ratio was used as a measure of the energy 
transfer efficiency.  
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2.6.4. Choice of Excitation, Emission and Dichroic Mirrors Used in FRET 
Microscopy 
 
The optical filter combinations in FRET microscopy were chosen to maximize the FRET 
signal while minimizing the fluorescence background due to direct excitation of acceptor 
molecules by donor excitation light. The optimal filter combination for the donor-
acceptor pair used in our experiments is shown in table 2.1. Specific combinations of 
filters were named as listed in the table 2.1.  
 
 
Table 2.1. Optimal filter combinations for fluorescence imaging used in FRET 
experiments. 
Channel (Ex/Em 
wavelength) 
Excitation filter Dichroic 
mirror  
Emission filter  
Donor/Donor (Donor) 480/30 nm  
(bandpass) 
505 nm 535/40nm 
(bandpass) 
Donor/Acceptor (FRET) 480/30 nm 
(bandpass) 
505 nm 590 nm (longpass) 
Donor/ Donor + Acceptor 460/50 nm 
(bandpass) 
500 nm 515 nm BA(longpass)
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CHAPTER 3 
FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) - A NEW 
ANALYTICAL METHOD TO MONITOR DRUG DELIVERY 
 
 
3.1. Introduction 
In conventional therapy, drug stability and bioavailability are the major areas of 
concerns. Modern delivery systems are expected to increase the activity of the drugs by 
using localized and triggered drug delivery [112]. New drugs, including gene therapy 
agents, require novel technologies for their delivery. Biodegradable polymers, stimuli-
sensitive polymers, kinetic- and equilibrium-modulated polymers or carriers that 
increase membrane permeability have been used to facilitate the delivery of drugs that 
are not cell permeable [113,118,121]. The most important requirements for effective 
drug delivery systems are [113]:  
- Sustained release of drug to reduce the frequency of dosing and local side effects. 
- Controlled release products, which have reliable and reproducible properties in 
different environments.  
- Spatial targeting of drugs to a specific organ, cell, subcellular compartment or to a 
specific substrate.  
Liposomes were used to deliver highly toxic drugs since liposomal 66
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encapsulation meets the above requirements [113-115]. Recently, liposomes have also 
been used to deliver proteins, antibiotics, anesthetics, oligonucleotides, antifungal and 
anticancer into cells and tissues [104,116-117].  For effective delivery liposomes are 
required to meet several criteria. First, they must evade the endosome/phagosome 
system and release their content to the targeted site. Second, the liposomes should 
have long circulation times in the blood stream. The recent use of sterically stabilized 
liposomes increased their stability in the blood stream and improved their resistance to 
phagocyte uptake [118-123]. Additionally, controlled release of the internal content of 
liposomes under different stimuli such as temperature [124-126], pH [127], light [128] 
and laser light [129] was realized. Although liposomal formulations often improve 
performance of drugs, effective delivery of drugs into targeted cells and organelle 
remain a challenge. Currently used analytical techniques (HPLC, GC, MS) offer reliable 
quantitative information about drug delivery into specific organs and tissues. However, 
the cellular fate of drugs cannot be evaluated using these techniques. Moreover, poor 
understanding of the pharmacodynamics at the cellular level is a serious impediment to 
improving the design of drug delivery systems. Confirmatory images could authenticate 
the delivery of drugs to specific cellular organelles and support the elucidation of 
pharmacodynamics data associated with specific drugs.  
Recently, intracellular delivery and binding affinity of newly developed drugs have been 
evaluated by sensitive luminescence methods. These methods are based on the 
interaction between a specific cellular receptor and the screened drugs.  The activity of 
the receptor when the drug binds to it is encoded in an enzyme activity, which is 
quantified by measuring the conversion of a fluorogenic or luminogenic substrate 
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[12,13,31,32]. Unfortunately, these assays cannot offer real time information about the 
drug delivery or the binding affinity since the fluorescent products are allowed to 
accumulate to overcome the intrinsic fluorescence of the cells.  
As previously mentioned, microscopy techniques have been employed for cellular 
studies in vitro [71, 73-75,133]. The limit of optical resolution of a microscope is about 
0.2 µm, which is the limit of light diffraction. This limitation is overcome by electron 
microscopy that can determine the location of specific drugs in particular cellular 
organelles with a resolution in the range of Å. However, electron microscopy does not 
offer real time information since it requires multiple preparative steps to acquire images.  
Therefore, a real time technique is needed to characterize drug interactions with specific 
cells, kinetics of drug delivery and drug leakage from cells. For example, quantification 
of unloaded drug or drug leakage from tumor cells is essential since anticancer drugs 
have harsh side effects on normal cells [113, 118, 121, 130]  
This chapter describes the use of FRET microcopy to measure in real time the delivery 
of fluorescent model-drugs into single cells. As previously mentioned the FRET 
efficiency depends largely on the distance between the donor and acceptor. FRET 
could be therefore used as a highly specific molecular ruler [131, 132].  FRET 
measurements were previously employed for the detection of co-localization of proteins 
in cellular membranes [73,133-134], hybridization of nucleic acids [135, 136], 
intracellular signaling [137, 138] and protein-protein interaction [139, 140]. The use of 
FRET imaging microscopy increased significantly following the recent discovery of the 
green fluorescent protein (GPF) and its mutants [141].  Fluorescence microscopic 
techniques have been often used to monitor the delivery of fluorescent molecules into 
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cells [142, 143]. However, using ordinary fluorescence microscopic techniques it was 
difficult to determine whether the fluorescent molecules truly permeate through the cell 
membrane or only adsorb to the cell surface. Although confocal microscopy indicates 
the localization of a fluorophore cells in a 3-dimensional space, this fluorescence 
microscopy technique cannot offer real time information since it is based on a lengthy 
laser scan across the specimen. We hypothesized that FRET measurements between 
fluorescent molecules preloaded into cells and permeating fluorescent molecules 
(donors or acceptors) would provide direct real time evidence that the fluorescent 
molecules truly permeate the cellular membrane. Fluorescein and Rhodamine 
derivatives were utilized as donor and acceptor molecules in our cellular studies.  We 
investigated two strategies for the energy transfer in cells. The first involved the delivery 
of donor molecules into acceptor labeled cells. The second strategy involved the 
delivery of acceptor molecules into donor-labeled cells. 
 
 
3.2. Specific Experimental and Technical Details 
 Materials and Reagents 
5-(and-6)-Carboxyfluorescein and Sulforhodamine were used in our FRET studies in 
solution. Fluorescein diacetate and Calcein AM were utilized as donors and 
Sulforhodamine and Cell Tracker Orange as acceptors in our cellular studies.  
Detection System 
A digital florescence imaging microscopy system was employed to measure the delivery 
of the donor and acceptor model drugs. The excitation, emission and dichroic filter 
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combinations were optimized to minimize the overlap between the donor and acceptor 
absorption and emission peaks. Three filter cubes were used for donor, acceptor and 
FRET imaging (table 2.1). The fluorescence images of macrophage cells were collected 
using a 40X and 20X microscope objectives with NA = 0.7 and NA=0.5 respectively. 
Typically an exposure time of 0.3 s was used to acquire fluorescence images of the 
particles. A 10 % transmission neutral filter density filter was used to minimize the 
photo-bleaching rate of the fluorophores. The Roper Scientific software Winview 3.2 
was used for image analysis. Additionally, the software Adobe PhotoShop v 3.0 and 
Image ProPlus v. 4.5 were utilized for image processing.  
 
Loading of Donor or Acceptor Dyes into Cells 
Stock solutions of 110 mM of donor and acceptor dyes in dimethylsulfoxide (DMSO) 
were prepared and used in our FRET experiments. Macrophage cells were grown on 
the chambered cover-glasses to 70% confluency. Preloading of macrophages with 
donor or acceptor molecules was accomplished by initially diluting the stock solution 
into fresh medium to final concentrations of 500 nM to 50 µM, then incubating the 
macrophages with the dye containing medium for 30 minutes at room temperature. 
Then, the excess of dye was washed out with PBS buffer (pH=7.4). The delivery of 
donor molecules into acceptor labeled cells was quantified and monitored after the 
addition of small aliquots of donor stock solution into the 400 µl PBS buffer (pH=7.4) 
covering the cell culture in the chambered coverglass. The buffer and the dye solutions 
were mixed cautiously with a disposable glass pipette. The same procedure was carried 
out to follow the delivery of acceptor model drugs into donor labeled macrophages. 
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3.3. Results and Discussion 
3.3.1 Choice of Donor and Acceptor Pair 
Fluorescein and Rhodamine derivatives have been utilized frequently in FRET 
microscopy since these dyes are characterized by high absorbance, emission quantum 
yield, large separation between the excitation and emission wavelengths and significant 
overlap between the donor emission and the acceptor absorption spectra [132c, 134]. 
This donor and acceptor pair is characterized by a large Forster distance (49-54 Å) that 
ensures large energy transfer efficiency.  
 
3.3.2 Photostability of the Donor and Acceptor Dyes Loaded in Murine 
Macrophage Cells 
 
The photostability of the donor and acceptor dyes was determined by recording the 
photobleaching rate after repetitive exposures to the excitation light. The Fluorescein 
based dyes showed a 50 % drop in their fluorescence after 10 exposures of 0.3 s. The 
Rhodamine based dyes had lower photobleaching rate. To minimize the photobleaching 
a neutral density filter with 10 % transmission was used in our experiments. Using this 
filter the photobleaching of fluorescence was reduced to about 5% following 30 minutes 
of continuous illumination. During the kinetic experiments the cells were exposed to the 
excitation light only during exposures of the sample to the CCD camera for an 
accumulative exposure time of about 1 minute. Under these conditions donor and 
acceptor labeled cells remain photostable throughout the experiments. Furthermore, 
monitoring the fluorescence intensity of the cells for one hour showed no leakage of 
fluorescent probes from observed cells with the exception of Fluorescein diacetate. This 
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dye was replaced with the Calcein AM that showed increased cellular retention and 
relative insensitivity of its fluorescence to pH changes in the physiological range. The 
cellular structure remained intact for at least 5 hours following cellular labeling with 
donor and acceptor molecules. 
 
3.3.3. Delivery of Donor Fluorophores into Acceptor Labeled Macrophages 
To monitor the delivery of donor molecules into acceptor labeled cells J774 murine 
macrophages were pre-incubated with 5 µM Sulforhodamine (acceptor). Then, the cell 
permeating dye Calcein-AM (donor) was added in small aliquots to the cultures. 
Fluorescence images of the cells were collected 15 minutes following the addition of 
Calcein-AM to the cultures. Digital fluorescence images of the murine macrophages 
loaded with Sulforhodamine prior and following the delivery of donor molecules are 
shown in figure 3.1.  
 
 
 
 
 
 
 
 
a        b 
 
Figure 3.1. Fluorescence images of Sulforhodamine (5µM) labeled murine 
macrophages prior (a) and following incubation with 25nM Calcein AM for 30 minutes 
(b). Fluorescence images were taken through the FRET channel (λex=480 nm, λem> 
590nm). 
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The cells were imaged trough a 40 X objective and the FRET channel (table 2.1). The 
permeation of Calcein AM into the cellular cytoplasm led to a noticeable increase in the 
FRET signal due to energy transfer between the permeating donors and the acceptor 
labeled cells. To correct the donor fluorescence tail contribution into the FRET channel, 
ratios between the intensities of the images obtained through the FRET channel 
(λex=480 nm, λem> 590nm), Fa, and donor channel (λex=480 nm, 520 nm >λem> 550nm), 
Fd, were calculated. Figure 3.2 shows the dependence of Fa/Fd ratio on increasing 
donor concentrations. Curves a and b describe the dependence of Fa/Fd ratio on the 
donor concentration in the presence and absence of Sulforhodamine. It can be seen 
that Fa/Fd of acceptor labeled macrophages was 2 fold larger than Fa/Fd of cells in the 
absence of acceptor molecules (the control experiment). The error bars were obtained 
from 3 different experiments. Each data point was the averaged intensity of 20 cells. 
The increase in Fa/Fd ratio in the absence of acceptor molecules was attributed to the 
red-tail emission of donor molecules. This phenomenon is often described in the 
literature as bleed-though and should be minimized to obtain quantitative FRET 
measurements. The bleed-through between the FRET and donor channels was largely 
noticeable at Calcein AM levels higher than 25 nM when only a small difference 
between the Fa/Fd ratio in the presence and absence of acceptor was seen. The major 
limitation of this FRET geometry was the small dynamic range of the assay.  
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Figure 3.2 FRET efficiency between Sulforhodamine (5 µM) labeled macrophages and 
increasing concentrations of the donor, Calcein AM. The FRET magnitude was 
determined by recording the increase in the ratio between the sensitized acceptor 
signal, Fa, and the donor fluorescence, Fd in the presence (a) and absence (b) of 
Sulforhodamine.  
 
 
3.3.4. Delivery of Acceptor Molecules into Donor Labeled Macrophages 
The high emission quantum yield of Calcein-AM combined with the low loading 
efficiency of Sulforhodamine was the major shortcoming of the previous FRET sensing 
geometry.  It resulted in a large red-tail emission of donor molecules in the FRET 
channel. To overcome this problem another geometry of FRET measurements was 
investigated. In these experiments the delivery of acceptor molecules into macrophages 
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preloaded with Calcein AM was monitored. The FRET efficiency was determined using 
the donor quenching method and was calculated as the ratio between the fluorescence 
intensity of the macrophages prior and following acceptor delivery (Fd/Fd0). 
In the initial experiments we used Sulforhodamine as an acceptor. Macrophages cells 
were preloaded with Calcein AM by incubating cell cultures grown in chambered cover-
glasses to 70% confluency with 400 µl 5 µM Calcein AM solution for 30 minutes at room 
temperature. The cells were washed out of the excess donor molecules with PBS buffer 
and then incubated with 400 µl 500 µM Sulforhodamine for 30 minutes at room 
temperature. The results of these experiments are summarized in figure 3.3. The upper 
curve (open circles) describes the control experiment in which the donor channel signal 
was measured in the absence of Sulforhodamine. As expected, no quenching of the 
donor florescence was observed. The lower curve (the filled squares) shows the 
decrease in fluorescence of Calcein AM labeled cells as Sulforhodamine permeates into 
macrophages. The decrease in the donor fluorescence was expressed as the ratio 
between the fluorescence of donor labeled cells prior (Fd0) and following (Fd) the 
delivery of Sulforhodamine. Given the errors in these experiments, the decrease of 
about 10% in the fluorescence of donor labeled cells was deemed insignificant. 
Furthermore, the limited quenching of the donor labeled macrophages was not acceptor 
concentration dependent. Poor cellular uptake and subsequent compartmentalization of 
Sulforhodamine could be the reasons for the minimal FRET efficiency between the 
donor molecules located in the cytoplasm and the acceptor molecules that were 
entrapped in the cellular endosomes. 
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Figure 3.3. Delivery of Sulforhodamine (500 µM) into Calcein AM (5 µM) labeled 
macrophages. The FRET magnitude was determined by recording the decrease in the 
ratio between the donor signals: (a) prior (Fd0) and (b) following the delivery of 
Sulforhodamine (Fd). Fluorescence images were taken through the donor channel 
(λex=480 nm, 520 nm > λem> 550nm). 
 
 
To increase the cellular uptake we encapsulated Suforhodamine in liposomes and used 
them as cargos for intracellular delivery. Liposomes were previously used to facilitate 
the cellular uptake of charged large molecules like the acceptor dye, Sulforhodamine 
[104]. pH sensitive liposomes were prepared to overcome the entrapment of 
Sulforhodamine in cellular endosomes. Several experiments were performed to find the 
optimal encapsulation method and liposomal formulation. Different encapsulation 
methods were attempted including direct injection, hydration-dehydration and the 
 
 69
freeze-thaw method [105]. The pH sensitive liposomes were composed of phosphadityl 
ethanol amine which does not form bilayers at physiological pH. The phospholipid 
bilayer was stabilized by negatively charged phospholipids, N-succinyl DOPE to form 
the liposomes. The freeze-thaw method was found to be the most suitable for these 
fusogenic liposomes [104]. Endosomes are cell organelles characterized by an acidic 
environment with a pH of about 5 [34, 35]. The negatively charged liposomes were 
initially entrapped in the endosomes where their negative charges were neutralized by 
the acidic environment (pH=5). The neutralization of the N-succinyl DOPE electric 
charge destabilized the liposome structure and facilitated their fusion with the 
endosomes membrane and the subsequent release of their content into the cytoplasm. 
 
 
Figure 3.4. Fluorescence image of J774 murine macrophages loaded with liposomes 
containing Sulforhodamine. The liposomes were prepared a phospholipid cocktail 
containing a mixture of DOPE: N-succinyl DOPE (7:3) using freeze-thaw method. The 
fluorescence image was taken through the acceptor channel (λex=546 nm, λem> 580nm). 
 
 
Figure 3.4 is an image of macrophages loaded with the cell impermeable 
Sulforhodamine through the liposomal mediated delivery. The murine macrophages 
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grown at the bottom of a chambered cover-glasses to 70 % confluency were incubated 
with the liposomes at the final lipid concentration of 10 mg/ml for 60 minutes at 37 0C. 
The cells were washed with PBS at pH=7.2 and then examined by fluorescence 
microscopy. The delivery efficiency of Sulforhodamine from pH sensitive liposomes 
increased greatly compared to the delivery efficiency of the free dye experiment. 
However, as seen in figure 3.4 compartmentalization of Sulforhodamine in the cells was 
still present.  
 
To overcome the compartmentalization of the acceptor molecules we replaced 
Sulforhodamine with a cell permeable dye, Cell Tracker Orange. Unlike 
Sulforhodamine, Cell Tracker Orange was not sequestered in endosomes. The FRET 
efficiency between the Calcein AM labeled cells and Cell Tracker Orange was 
determined based on the fluorescence decrease of Calcein AM as Cell Tracker Orange 
molecules permeated into the cells. It was again expressed as the ratio between the 
donor fluorescence in the presence and absence of acceptor molecules in the cells 
(Fd/Fd0). In these experiments macrophages grown on the on the bottom of chambered 
cover-glasses to 70% confluency were first incubated with 400 µl 5 µM Calcein AM 
solution for 30 minutes at room temperature. The excess of Calcein AM was washed 
with PBS buffer at pH 7.2. Then, the cells were incubated with increasing 
concentrations of Cell Tracker Orange solutions ranging from 50µM to 500 µM. 
Fluorescence images of murine macrophages preloaded with Calcein AM (5 µM) prior 
(a) and following (b) the delivery of Cell Tracker Orange (500 µM) are shown in figure 
3.5. The decrease in Calcein-AM fluorescence resulted from FRET between Cell 
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Tracker Orange molecules delivered into the observed macrophages and the Calcein 
AM labeled cells.   
As evident in figure 3.6 the Calcein AM fluorescence decreased by about 40% when 
CalceinAM labeled cells were incubated with 500µM Cell Tracker Orange for 30 minutes 
(figure 3.6., triangle dots). Longer exposure times did not increase the donor quenching 
magnitude. Lower acceptor concentrations like 250µM resulted in slower donor 
quenching (figure 3.6., filled circles). The use of acceptor molecule permeation into 
donor labeled cells (strategy 2) in our FRET measurements proved to be more effective 
than the use of permeating donor molecules into acceptor labeled cells (strategy 1).  
 
 
 
 
 
 
 
 
 
 
 
a)       b) 
 
Figure 3.5. Fluorescence images of the Calcein AM (5 µM) labeled murine 
macrophages prior (a) and following incubation with 500 µM Cell Tracker Orange for 30 
minutes (b). Fluorescence images were taken through the donor channel (λex=480 nm, 
520 nm > λem> 550nm). 
 
However, a relatively high acceptor concentration in the hundreds micromolar level was 
still needed to obtain measurable FRET signals in a 3-D system like the cellular milieu. 
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As evident in figure 3.6 the Calcein AM fluorescence decreased by about 40% when 
Calcein AM labeled cells were incubated with 500µM Cell Tracker Orange for 30 
minutes (figure 3.6, triangle dots). Longer exposure times did not increase the donor 
quenching magnitude. Lower acceptor concentrations like 250µM resulted in slower 
donor quenching (figure 3.6., filled circles).  
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Figure 3.6.  Delivery of CellTracker Orange into CalceinAm labeled macrophages 
monitored by FRET. Donor channel fluorescence was recorded in the absence of 
(square dots), the presence of  250µM (filled circle dots) and 500µM (triangle dots) 
CellTracker Orange. 
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The use of acceptor molecule permeation into donor labeled cells (strategy 2) in our 
FRET measurements proved to be more effective than the use of permeating donor 
molecules into acceptor labeled cells (strategy 1). However, a relatively high acceptor 
concentration in the hundreds micromolar level was still needed to obtain measurable 
FRET signals in a 3-D system like the cellular milieu. 
 
 
3.4. Summary and Conclusions 
Fluorescence resonance energy transfer (FRET) was utilized to confirm for the first time 
the delivery of model fluorophores into single cells. Unlike previously used analytical 
techniques (HPLC, GC), FRET microscopy provided valuable information about 
fluorophore localization in cells. Furthermore, using FRET microscopy, we were able to 
quantitatively monitor in real time the kinetics of the delivery of fluorescent molecules 
into cells. Real time measurements were not previously possible when other imaging 
techniques like electron microscopy and confocal microscopy were used for cellular 
imaging. The delivery of fluorophores was followed by FRET in two systems. First, we 
studied the delivery of fluorescent donors into acceptor labeled cells.  Then, we studied 
the delivery of fluorescent acceptors into donor labeled cells. 
The delivery of donors into acceptor labeled macrophages led to an increased signal in 
the FRET channel. The measurements of donor delivery exhibited poor dynamic range 
due to the large donor emission tail in the sensitized acceptor channel, often described 
as bleed-through. In spite of the bleed-through effect it was possible to conclude that 
FRET microscopy could be used to confirm the delivery of donor molecules into 
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acceptor labeled cells. Monitoring the delivery of acceptor molecules into donor labeled 
macrophages proved to be easier and less prone to errors since only the donor 
emission was monitored using a single cube.  Initial attempts focused on the delivery of 
Sulforhodamine into cells preloaded with Calcein AM. Sulforhodamine is a cell 
impermeable dye. It was sequestered in endosomes, which decreased the FRET 
efficiency. We successfully used fusogenic liposomes to deliver Sulforhodamine into 
cells. However, while the loading efficiency improved significantly, compartmentalization 
of the delivered fluorophores was still noticeable. This precluded the use of FRET to 
monitor the interactions between Sulforhodamine and cells preloaded with Calcein ÅM. 
Sulforhodamine was then replaced with the cell permeable dye Cell Tracker Orange. 
Then, using donor labeled cells it was possible to determine whether the acceptor 
molecules were actually delivered into the cells. It was also possible to determine the 
localization of delivered acceptors, for example in endosomes or in cytoplasm. 
However, a relatively high acceptor concentration in the hundreds of micromolar level 
was still needed to obtain measurable FRET signals in the 3-D cellular system. The 
results underscored the need to reduce the dimensionality of FRET systems in order to 
increase FRET efficiency between donor and acceptor molecules.  
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CHAPTER 4 
FLUORESCENCE RESONANCE TRANSFER (FRET) SENSING LIPOBEADS FOR 
BIOANALYSIS 
 
4.1. Introduction 
A large number of drugs with different chemical structure and broad pharmacological 
spectrum drugs bind strongly to phospholipid membranes. Examples include: the 
anticancer drug doxorubicin [144,145], the aminoglucosidic antibiotic gentamicin [146, 
147], the β-adrenergic drug propanolol [148,150], local anesthetics such as lidocaine 
and pore forming antibiotics like gramicidin and polymyxin [151-153]. The ability of 
drugs to interact and permeate through cellular membranes is often correlated with drug 
potency. Several techniques have been used to investigate interactions of drugs with 
phospholipid membranes. These include fluorescence polarization [154], Brewster 
angle microscopy [155], NMR [156], differential scanning calorimetry [157] and FT-IR 
spectroscopy [158]. These approaches generally lack sufficient sensitivity, selectivity 
and temporal resolution. There is therefore a need for less invasive sensitive technique 
for real time monitoring of interactions between drugs and phospholipid membranes.  
 
Liposomes have proved to be useful for studying interactions of drugs with phospholipid 
membranes [159]. The main drawback of this technique is the inherent instability of 
liposomes that often causes irreproducibility in the measurements. Recently developed 
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phospholipid supported membranes that consist of a polymer or silica matrix in which 
phospholipids are absorbed or covalently bound to the surface of the particles proved to 
be useful in the design of steadier sensors for drug discovery [160,161]. The 
phospholipid layers were used mainly to accommodate membranal proteins that were 
the biological receptors of the screened drugs. However, the majority of these sensors 
did not provide information regarding the kinetics of the recognition reaction between 
the screened drugs and their receptors. Additionally, these sensors could not be used 
for intracellular studies because of their large size. In our laboratory, we recently 
developed a new type of particle-based miniaturized sensors named lipobeads. 
Lipobeads are micrometric polymeric particles coated with a phospholipid membrane. 
Hydrophobic and hydrophilic fluorescent probes could be entrapped in their 
phospholipid membrane providing the possibility to assay different intracellular analytes 
that interact with these specific fluorophores. Intracellular pH and oxygen levels were 
successfully measured using lipobead based sensors [34, 35]. Lipobeads have 
demonstrated high physical stability and low leakage rate. Moreover, they can be used 
as platforms for different types of interactions since their design is very versatile. 
 
As new formulations of drugs become available it is important to determine and quantify 
various effects of these drugs on membranes. Valuable information concerning the 
design of new therapeutics can be obtained by correlating the effect of drugs on 
membranes of different compositions. This chapter evaluates the use of fluorescence 
resonance energy transfer (FRET) sensing lipobeads to investigate interactions 
between fluorescent dyes and phospholipid membranes. The optical signal resulted 
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from FRET between donor labeled phospholipids and acceptor molecules that partition 
into the phospholipid membrane (figure 4.1). The cellmembrane -like phospholipid layer 
of FRET sensing lipobeads increases their biocompatibility and makes them suitable for 
future intracellular measurements.  
 
Nakashima and colab previously showed that FRET efficiency is 100 times higher in 
membranes than in solution [162,163]. They used Rhodamine and Malachite Green as 
donor-acceptor pair. The acceptor concentration required for quantitative FRET was in 
the range of tens of µM compared to hundreds µM in solution. Therefore, we predicted 
that the sensitivity of our FRET sensing lipobeads would increase compared to FRET 
sensitivity in solution. 
 
 
 
Acceptor 
FRET 
Donor labeled lipobeads 
 
Figure 4.1. A schematic diagram illustrating the principle of FRET sensing lipobeads.  
Adsorption or biding of fluorescent acceptor molecules to lipobeads containing a 
fluorescent donor results in FRET signal enhancement. 
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4.2. Specific Experimental and Technical Details 
Materials and Reagents  
N-(Fluorescein-5-thiocarbomyl)-1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine(Fluorescein-DHPE), Carboxyfluorescein and Sulforhodamine 
were obtained from Molecular Probes, Inc. Solid hydrophobic polystyrene microspheres 
with an average  diameter of 1.6 µm (±1% variation) were purchased from  Bangs 
Laboratory, Inc. Aqueous solutions were prepared with 18 M  deionized water produced 
by Barnstead Thermolyne Nanopure water purification system. Phosphate buffer (PBS, 
100mM, pH=7.2) was obtained from Amresco. 1,2-Dimyristoyl-sn-glycero-3-
phosphocholine (DMPC), 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (PE), 
and 1,2-dimyristoyl-sn-glycero-3-phosphate monosodium salt (DMPA) were from Avanti 
Polar Lipids. Chloroform, methanol, cholesterol (CH) and dihexadecyl phosphate (DP) 
from were purchased Sigma. All reagents were used as received.  
 
Synthesis of Fluorescent Lipobeads 
 Fluorescent lipobeads were synthesized based on a modified procedure originally 
described by Jin, J. et al [35]. The 1.6-µm polystyrene beads (4 mg/ml) were suspended 
in a 1:1 (v/v) ethanol/hexane solution and mixed with 80 µl 50 mM phospholipid cocktail 
in methanol: chloroform 1:1(v:v). The phospholipid cocktail (9:1 molar ratio) was 
prepared with DMPC and DMPA. To prepare donor labeled lipobeads 0.5-3% 
Fluorescein-DHPE (molar percentage) was added in the phospholipid cocktail. Several 
other phospholipid cocktails such as DMPC: PE=9: 1; DMPC: CH: DP=5:4:1 and DMPC 
were used to study the incorporation of Fluorescein-DHPE on different phospholipid 
 79
membranes. The beads and phospholipid suspension were incubated for 2 hours at 
room temperature and then dried out under nitrogen stream over night. The dried 
particles were resuspended in 2ml PBS buffer pH=7.4 with mild sonication. The excess 
phospholipid and uncoated particles were separated from lipobeads by centrifugation at 
3000rpm for 15 min. The phospholipid coated particles were washed three times with 
the same buffer until no fluorescence background was noticed.  
 
Energy Transfer Measurements 
The excitation and emission spectra of fluorescent dye solutions were obtained using a 
spectrofluorimeter (PTI International, model QM-1), equipped with a 75-Watt continuous 
Xe arc lamp as a light source. For measuring the fluorescence of FRET sensing 
lipobeads, the excitation wavelength was set at 470 nm. The emission spectra were 
recorded at room temperature in the spectral range of the donor and acceptor dyes 
(Fluorescein and Rhodamine) from 490 to 700nm. The excitation and emissions slits 
were set at 4 nm. Three consecutive scans were averaged to obtain a single spectrum. 
A sample cell with 1 cm optical pathlength and 3 ml volume was used in the fluoremetric 
experiments. To eliminate the influence of turbidity and differences in the lipobead 
donor-labeling yield the ratio of the acceptor and donor fluorescence (FA/FD) was 
computed from each spectrum. The emission of peaks of the donor and acceptor were 
at 515 nm and 590 nm respectively. Digital fluorescence images of the FRET sensing 
lipobeads were acquired trough a microscope objective (40X) with a filter cube 
containing a 480 nm +/- 30 nm excitation filter, 505 dichroic mirror and 515nm long pass 
emission filter. 
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4.3. Results and Discussion 
4.3.1. Choice of Fluorescent Indicators 
Fluorescein and Rhodamine were used frequently as donor-acceptor pair in FRET 
applications since they are characterized by high absorbance, large emission quantum 
yield, sufficient separation between the excitation and emission wavelengths and 
significant overlap of donor emission and acceptor absorption spectra [50,167]. In this 
work, the Fluorescein derivative 1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine(Fluorescein-DHPE) was used as a donor. The structure of the 
labeled phospholipid is shown in figure 4.2.  Fluorescein-DHPE is a membrane surface 
probe that has been used for both local electrostatic potential and pH measurements 
[30, 31]. Since the fluorescent probe was covalently attached to the phospholipid, the 
leakage of dye molecules from the sensing particles was prevented. Dye leakage is one 
of the most common problems of fluorescence sensors that are prepared by physically 
entrapping fluorescent dyes in a sensor matrix. The Fluorescein label was exposed 
toward the aqueous solution, outside of the phospholipid layer, since the fluorescent 
dye was covalently bound to the phospholipid head group (figure 4.2). 
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Figure 4.2. Structure of the donor labeled phospholipid used to label the FRET sensing 
lipobeads:N-(fluorescein-5-thiocarbamoyl)-1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine triethylammonium salt (Fluorescein-DHPE). 
 
 
4.3.2. Characterization of Donor Labeled FRET Sensing Lipobeads 
A fluorescence image of FRET sensing-lipobeads averaging 1.6 µm in diameter is 
shown in figure 4.3. The image was taken using a 40X microscope objective and a 500 
msec exposure time. Digital image analysis indicated that the ratio between the signal 
of the individual lipobeads and the background was approximately 250. The particles 
were evenly coated with fluorophores and they showed some aggregation. A 15% 
variation in the fluorescence intensity of the lipobeads was observed, suggesting that 
multilamellar films formed on some of the polystyrene particles.  
 
 
 
 82
 
 
 
 
 
 
 
 
Figure 4.3. Digital fluorescence image of 1.6 µm FRET sensing lipobeads. The image 
was taken through an excitation filter: λex=480 nm, a dichroic mirror: 505nm; an 
emission filter: λem>515 nm; objective: 40X with N.A= 0.7and a neutral density filter: 1.0 
for 0.5 seconds. 
 
 
4.3.2.1. Photostability of Lipobeads 
The photostability of donor labeled lipobeads was tested by placing a sample of the 
fluorescent lipobeads on the microscope stage and continuously illuminating it at 480 
nm. The fluorescence intensity of the lipobeads decreased by approximately 30% after 
20 consecutive exposures. To overcome the inherent instability of Fluorescein, the 
lipobeads were exposed to the excitation light for only 0.3 s in each measurement. The 
number of exposures of the lipobeads was limited to 20.  Additionally, a 0.1 OD neutral 
density filter was used to decrease the excitation intensity. Under these illumination 
conditions, all fluorophore molecules used in our experiments remained photostable 
throughout the experiments. No photobleaching occurred when the spectra were 
acquired with the fluoremeter. 
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4.3.2.2. Influence of the Phospholipid Composition on the Donor Absorption in 
the Lipobead Membrane 
 
As described in detail in the experimental section, we labeled lipobeads with 
Fluorescein-DHPE. The synthesis of the fluorescent particles was first optimized to 
achieve maximum fluorescence intensity and FRET sensitivity. Several other 
phospholipid cocktails were used to achieve the highest Fluorescein-DHPE absorption 
on the beads and better lipobead dispersion in aqueous solutions. The signal to noise of 
the Fluorescein labeled lipobeads composed of different phospholipids is shown in 
figure 4.4. 1% Fluorescein-DHPE was used to label all lipobead compositions. The 
brightest lipobeads were obtained when a 9:1 DMPC: DMPA cocktail was used to 
prepare the lipobeads. Since DMPA is positively charged at pH 7.2, the FRET sensing 
lipobeads showed reduced aggregation compared to lipobeads prepared using other 
phospholipid cocktails. Consequently, a 9:1 DMPC: DMPA cocktail was used to prepare 
FRET sensing lipobeads. 
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Figure 4.4. Effect of the composition of the phospholipid cocktail on the fluorescence 
intensity of FRET sensing lipobeads. DMPC=1,2-Dimyristoyl-sn-glycero-3-
phosphocholine, PE=1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, 
CH=cholesterol, PE= dihexadecyl phosphate, DMPA=1,2-dimyristoyl-sn-glycero-3-
phosphate monosodium salt.  
 
 
4.3.2.3. Energy Transfer Efficiency of FRET Sensing Lipobeads 
To test the FRET efficiency between donor labeled lipobeads and acceptor molecules, 
FRET sensing lipobeads solutions, that were adjusted to yield a fluorescence signal 
comparable to a solution of 500 nM Carboxyfluorescein, were mixed with 
Sulforhodamine. Fluorescence spectra of 1% Fluorescein-DHPE lipobeads in solution at 
different acceptor concentrations are shown in figure 4.5. The donor fluorescence was 
quenched and the acceptor fluorescence was sensitized with increasing concentrations 
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of Sulforhodamine. The changes and the wavelength shifts in the donor and acceptor 
signals resulted from FRET and inner filter effects [14, 49].     
 
 
 
 
Figure 4.5. Fluorescence spectra of FRET sensing lipobeads in the presence of 
different Sulforhodamine concentrations: a) 0 µM, b) 10.0 µM, c) 20.0 µM, d) 40 µM. 
The spectra were not corrected for the inner filter effect contributions. 
 
 
A comparison between the FRET efficiency of Fluorescein labeled lipobeads and free 
Carboxyfluorescein in solution in the presence of Sulforhodamine is shown in figure 4.6. 
The ratio Fa/Fd is used as a measure of FRET efficiency. It can be seen that Fa/Fd is 
acceptor concentration dependent. The FRET efficiency between the lipobeads and the 
Sulforhodamine was consistently 3-fold higher than FRET between Carboxyfluorescein 
and Sulforhodamine at any given acceptor concentration.  
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Figure 4.6. The variation of energy transfer efficiency (Fa/Fd) against increasing 
acceptor concentration for; a) FRET sensing lipobeads and b) Carboxyfluorescein 
solution (500nM). 
 
 
4.4. Summary and Conclusions 
A general scheme for sensitive detection of fluorescent acceptors using FRET based 
sensing lipobeads was developed. Using lipobeads labeled with Fluorescein we 
developed a method to evaluate the interaction of acceptor molecules with the 
phospholipid membrane of the lipobead-based sensor. The FRET efficiency between 
acceptor molecules that partitioned between solution and the donor labeled lipobeads 
was found to be approximately 3-fold larger than FRET efficiency between the donor 
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and acceptor molecules when dissolved in solution. The increase in energy transfer 
efficiency can be attributed to partition of acceptor molecules into the phospholipid layer 
membrane of the polymer beads, which increases the probability of FRET between the 
donor and acceptor molecules. As was hypothesized the change in the dimensionality 
of the system in which FRET occurs, improved the sensitivity of our measurements. 
However, the improvement in the sensitivity was lower than expected due to 
contributions from inner filter effects. We concluded that a biomolecular recognition 
component must be added to the FRET sensing lipobeads in order to decrease the 
acceptor concentration required for high FRET efficiency. We further hypothesized that 
adding a biomolecular recognition element would also decrease inner filter effects 
contributions and enable detection of non-fluorescent inhibitors based on their ability to 
compete on binding sites with acceptor molecules. These conclusions were the basis of 
a study, which is described in the next chapter of this dissertation. It focuses on the 
development of new miniaturized FRET based sensors for the detection of 
nonfluorescent carbohydrates and glycoproteins.  
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CHAPTER 5 
DESIGN, SYNTHESIS AND APPLICATION OF PARTICLE-BASED FRET SENSORS 
FOR SCREENING CARBOHYDRATES AND GLYCOPROTEINS  
 
5.1. Introduction 
Molecular fluorescence probes have emerged in the last two decades as useful tools for 
the analysis of biological fluids. Recently, these probes were immobilized to particles to 
form particle-based fluorescence sensors. For example, Kopelman et al developed and 
applied particle-based nanosensors for intracellular measurements of various 
physiologically important ions [170-173].  In our laboratory we prepared phospholipid 
coated submicrometric fluorescent polymer particles and employed them to quantify the 
pH and molecular oxygen levels in murine macrophages and the release of zinc ions 
from stimulated neuron cells in culture [21,34,35,174]. Due to their miniaturized 
dimensions particle-based sensors are less invasive and less destructive than larger 
sensors.  Their temporal and spatial resolution is inversely dependent on their size due 
to decreasing spatial dimensions and increasing surface over bulk ratio with decreasing 
particle size. The nanometric dimensions of these sensors enable site-specific and rapid 
measurements in biological samples. Furthermore, it is possible to employ digital 
fluorescence imaging microscopy systems for multiplexed analysis of a large number of 
particles simultaneously.   
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In particle-based fluorescence sensors the fluorescence indicator is entrapped in a 
polymer matrix that minimizes interactions of the fluorescent indicator with possible 
interfering substances. This protection increases the chemical stability of particle-based 
sensors in biological samples and decreases their cytotoxicity [175]. Currently used 
particle-based fluorescence sensors are based on a direct interaction between 
fluorescent indicators and their corresponding analytes.  These sensors are restricted to 
a limited number of analytes that include pH, cations and molecular oxygen.  The 
incorporation of enzymes and antibodies for analyte recognition has largely expanded 
the scope of analytes that could be determined with fluorescence sensors [176-179].  
Nevertheless, there is still a need to develop new signal transduction mechanisms that 
could be coupled to biorecognition components like enzymes and antibodies in 
miniaturized sensors.  
Fluorescence resonance energy transfer (FRET) is a fluorescence phenomenon during 
which the energy of an excited donor molecule is transferred non-radiatively to an 
acceptor molecule [14]. FRET spectroscopy has been used frequently in studying 
protein-protein interactions and protein conformational changes [180, 181].  The use of 
FRET microscopy practically extends the spatial resolution of optical microscopes since 
FRET occurs only when the donor and acceptor molecules are in close proximity (1-
10nm) [182].  FRET has been previously applied in biosensors that use a change in 
protein or DNA oligomer conformation due to interactions with analyte molecules as a 
basis for molecular recognition [183].  In this study we developed particle-based FRET 
sensors for screening carbohydrates and glycoproteins.  The detection principle was 
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based on selective carbohydrate-protein interactions between carbohydrates and 
concanavaline A (ConA), a lectinic protein.   
The evaluation of protein-carbohydrate interactions is not trivial because the binding 
mechanism and the parameters that affect the binding affinity between carbohydrates 
and proteins are not fully understood [184].  The most utilized method to quantify 
carbohydrate-lectin interactions measures the ability of a soluble carbohydrate to inhibit 
the agglutination and precipitation of lectins, which are induced by a multivalent 
saccharide [185].  The absorption of the mixture is monitored at different carbohydrate 
concentrations.  The carbohydrate inhibition efficiency is expressed as IC50, which is the 
inhibitor concentration required to decrease the absorption signal by 50%.  Although 
simple, this technique is time consuming and the results are often irreproducible.  More 
recently, surface plasmon resonance (SPR) binding assays were used successfully to 
measure carbohydrate-protein interactions [186-188].  SPR methods have the ability to 
monitor binding events in real time and without labeling. While the assays are highly 
sensitive their selectivity remained a problem as SPR sensors are largely affected by 
non-specific interactions. 
Recent literature reports have led us to hypothesize that it would be possible to employ 
FRET based micrometric sensors to screen carbohydrates or glycoproteins based on 
their selective interaction with carbohydrate binding proteins like ConA.  For example, 
Kiessling et al [186, 187] investigated the control of multivalent interactions involving 
lectins and new classes of polyvalent carbohydrate ligands. The efficiency of FRET 
between a donor and an acceptor labeled ConA that bound to the same multivalent 
ligands was indicative of the lectin-carbohydrate interactions.  Glucose monitoring by 
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the interaction of ConA with monomeric glucose was reported by Schultz and coworkers 
who used several experimental setups for this purpose [178].  For example, they 
developed a novel fluorescence hollow fiber sensor for transdermal glucose monitoring 
based on the competitive and reversible binding of FITC-ConA to colored sephadex 
beads in the presence and absence of free glucose.  In this study, we used FRET as an 
optical signaling strategy to monitor the binding of carbohydrates and glycoproteins to 
polymeric particles labeled with FITC-ConA.  We determined the ability of monomeric 
carbohydrates and glycoproteins to inhibit the binding between Texas Red-labeled 
dextran (dextran-TR) and the FITC-ConA labeled particles (figure 5.1).  The optical 
signal resulted from FRET between the fluorescein labeled ConA and the Texas Red-
labeled dextran molecules.  In the inhibition assays the particles were pre-incubated 
with unlabeled carbohydrates or glycoproteins prior to adding dextran-TR to the 
samples.  The FRET efficiency between FITC-ConA and dextran-TR decreased with 
increasing the concentration of binding inhibitors. The analytical properties of these 
newly developed particle-based FRET sensors and their potential use in carbohydrate 
and glycoprotein screening applications are discussed. 
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Figure 5.1. Illustration of the Particle-Based FRET Sensors for Screening 
Carbohydrates and Glycoproteins. FRET sensing particles in the absence (top) and 
presence (bottom) of glycoprotein or carbohydrate inhibitors.  The FRET efficiency 
decreases with increasing inhibitor concentrations. 
 
 
 
5.2. Specific Experimental and Technical Details 
Synthesis of FRET Sensing Particles 
FITC-ConA labeled particles were synthesized by suspending 1.6-µm polystyrene 
particles [16 mg/ml, 107 beads/ml) in a 200µg/ml FITC-ConA HEPES buffer solution at 
pH 7.2 for 3 hours at room temperature. The HEPES buffer solution contained 100 mM 
HEPES, 150 mM NaCl, and 1mM Ca2+ and Mn2+.  Lectin molecules adsorbed strongly to 
the hydrophobic polystyrene particles and leakage of the proteins to aqueous solution 
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was negligible for months.  The excess protein and uncoated particles were separated 
from the lectin-coated particles by repeated cycles of precipitation by slow speed 
centrifugation (3000 rpm for 15 min) and resuspension in HEPES buffer solution at pH 
7.2.  The ConA-coated particles were washed until no fluorescence background from 
free FITC ConA molecules was noticed. The FITC-ConA particles were further 
incubated with 1mg/ml bovine serum albumin (BSA) for two hours.  BSA was used as a 
blocking solution to minimize non-specific adsorption of acceptor molecules on the 
particles.  The particles were washed of excess BSA using three cycles of precipitation 
by centrifugation and resuspension in HEPES buffer.  The particles were finally 
suspended in 5 mL HEPES (100mM, 150 mM, NaCl, pH=7.2) solution and stored at 4
C until use.  The density of lectin receptors on the particles was estimated to be around 
105 molecules/particle or 10-12 mole/cm2.  The number of FITC-ConA molecules 
absorbed on the surface of the particles was calculated by measuring the absorption of 
the supernatant at 280 nm prior and following labeling the particles with FITC-ConA.  
The concentration of FITC-ConA in the supernatant was calculated by using UV 
absorption at 280 nm, A280 = 1.37 x [mg/ml ConA] [187].  The amount of lectins per 
particle was estimated from dividing the total concentration of FITC-ConA absorbed on 
the particles by the concentration of the particles in the solution. All buffers used in the 
experiments were autoclaved to minimize bacterial growth 
 
Digital Fluorescence Imaging Microscopy and Spectroscopy  
The fluorescence images of the FRET sensing particles were collected using a 20X 
microscope objective with NA = 0.5. Exposure times of 0.2 sec and 0.5 sec were used 
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to acquire the fluorescence spectra and images of the particles respectively.  A 0.6 OD 
transmission neutral density filter was used to decrease the excitation light intensity of 
the 100-W microscope mercury lamp in order to minimize photo bleaching of the 
fluorophores.  
 
Immobilization of FRET sensing particles on the surface of a multi-well 
chambered cover glass  
A multi-well chambered cover glass [borosilicate, Nalge Nunc International) was 
washed with 70% ethanol/water, followed by a thorough rinse with deionized water.  
The cover glass was incubated overnight with 1% poly-L-lysine. The wells were then 
rinsed with deionized water and a working HEPES buffer at pH 7.2.  A 5µl FRET 
sensing particles suspension was added to 200 µL HEPES buffer.  The solution was 
added to a glass well and incubated for 4 hours at room temperature to facilitate the 
physical attachment of FRET sensing particles to the polylysine coated glass surface.  
The glass wells were washed form unbound FRET sensing particles using the HEPES 
buffer solution.  This step was done with care to minimize contact of the micropipette 
used to remove the solution with the polylysine layer attached to the glass well surface.    
 
Dextran-TR binding studies - To study the binding of dextran-TR to the FITC-ConA 
labeled particles we first attached the FITC-ConA labeled particles to the polylysine 
coated wells of the chambered cover glass.  Then, a solution of 400 µL HEPES buffer at 
pH 7.2 with 1mM Ca2+ and Mn2+ was added to each well.  Small aliquots of concentrated 
dextran-TR (2-4 µl) were added and the solution was mixed with a Pasteur pipette.  The 
final concentrations of dextran-TR ranged from 0 to 15 µg/ml.  The dextran-TR binding 
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was monitored for 15 minutes until no changes in the donor and acceptor fluorescence 
was observed.  
 
FRET inhibition assays  The inhibition assays were performed in a chambered cover 
glass and were monitored using digital fluorescence imaging microscopy.  The 
decrease in donor fluorescence was used to quantify the FRET inhibition efficiency.  To 
carry out the inhibition assays the polylysine coated wells were first incubated with 
5x104 FITC-ConA labeled particles.  Unbound particles were washed with a HEPES 
buffer solution at pH 7.2.  Then, 200 µL HEPES buffer solution aliquots containing 
FRET inhibitors at various concentrations were added to the wells.  The sample 
solutions were incubated for 1 hour at room temperature. Then, dextran-TR solution 
was added to each well at a final concentration of 1.2 µg/ml and the solution was mixed 
thoroughly with a Pasteur pipette.  Digital fluorescence images from each well were 
taken immediately and 15 minutes following the addition of dextran-TR.  Longer 
incubation times did not induce larger changes in the donor and acceptor fluorescence.  
The fluorescence intensity of the FRET particles at 15 minutes was normalized to the 
initial fluorescence intensity taken immediately following the addition of dextran-TR to 
the wells.  Each assay was repeated 3 times for error analysis purposes.  The digital 
fluorescence images were acquired using the image analysis software Image ProPlus v 
4.5.  The Micro Cal Origin v 7.0 software was used for data analysis.  
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5.3. Results and Discussion 
5.3.1. Choice of Fluorescent Indicators 
Fluorescein and Texas Red have been used frequently in FRET applications because of 
their high absorbance, emission quantum yield, large separation between the excitation 
and emission wavelengths and the significant overlap between the donor emission and 
the acceptor absorption spectra [189-191].  The absorption and emission spectra of 
Fluorescein and Texas Red are shown in figure 5.2.  The overlap integral between the 
Fluorescein emission and Texas Red absorption is marked with diagonal lines.  In 
selecting the donor-acceptor pair we also considered using Rhodamine derivatives 
rather than Texas Red as acceptor molecules.  While the overlap integral between 
Fluorescein and Rhodamine was 2-fold larger than the overlap integral between 
Fluorescein and Texas Red, the signal to noise ratio was higher for the Fluorescein-
Texas Red donor-acceptor pair.  This was attributed to the minimization of leakage 
between the donor and acceptor channels, often described as bleeding [75, 192].  It 
results from direct excitation of acceptor molecules by the excitation light.  It must be 
minimized to enable quantitative analysis of binding events between donor and acceptor 
labeled biomolecules as well as quantitative analysis of binding inhibitors.  
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Figure 5.2.  Absorption and fluorescence spectra of Fluorescein and Texas Red. The 
area marked with diagonal lines represents the overlap integral between the donor 
emission and acceptor absorption.  
 
 
5.3.2. Characterization and Properties of the FRET Sensing Particles 
As described in detail in the experimental section, we labeled polystyrene particles with 
FITC-ConA, a glucose/mannose binding protein. The synthesis of the fluorescent 
particles was optimized to realize maximum fluorescence intensity and sensitivity to 
dextran-TR binding.  Further studies were performed to determine the dose response 
and the response time of the FRET signal to changes in dextran-TR concentration.  To 
maximize the fluorescence intensity of the FRET sensing particles we prepared FITC-
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ConA labeled particles in FITC-ConA solutions of increasing concentrations from 10 to 
500 µg/ml.  The fluorescence intensity of the FITC-ConA labeled particles was 
measured in 5 fields of view on the surface of a microscope cover slip.  The 
fluorescence intensity of the particles increased with increasing FITC-ConA 
concentration in the preparation solution up to a concentration of 200 µg/ml.  Then, the 
fluorescence intensity decreased probably due to fluorescence self-quenching between 
adjacent FITC molecules.  The FRET sensing particles exhibited bright fluorescence 
with a signal-to-noise ratio (S/N) of 50.  A 10% variation in their fluorescence intensity 
was observed, suggesting that the FITC-ConA was not distributed uniformly on the 
polystyrene particles or that the number of fluorescein molecules per ConA molecule 
varied to some degree.  
 
5.3.3. Photostability and Leaking Stability of the FRET Particles 
To test the photostability of the FITC-ConA labeled particles we attached FRET sensing 
particles to a multi well chambered cover glass as described in the previous section.  
The chambered coverglass was placed on the stage of an inverted fluorescence 
microscope.  The FRET sensing particles were then continuously illuminated using the 
100 Watt lamp of the microscope.  Fluorescence images of the particles were obtained 
periodically.  The fluorescence intensity of the FRET sensing particles decreased by 
about 30% during the first 5 minutes of continues illumination. To overcome the 
inherently poor photostability of FITC we used a 0.6 OD neutral density filter to reduce 
the excitation intensity.  Additionally, the particles were exposed to the excitation light 
for only 0.5 sec in each measurement and the number of exposures was limited to 30 
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during a typical binding experiment.  Under these illumination conditions, all fluorophore 
molecules used in our experiments remained photostable throughout the 
measurements.  The FRET sensing particles were stored in a 100 mM HEPES and 150 
mM NaCl buffer solution at pH 7.2 and 4 C.  Under these storage conditions, the 
particles maintained the ConA binding activity with minimal dye leakage and no 
noticeable aggregation.  The performance limiting factor of the FRET sensing particles 
was found to be their carbohydrate binding activity.  When suspended in solution the 
FITC-ConA labeled particles retained their carbohydrate binding activity for only 4-5 
days.  This could be attributed to bacterial growth, which is known to affect the binding 
activity of lectins [193].  
 
5.3.4. Dextran-TR Binding Studies 
The stable immobilization of FRET sensing particles to the polylysine coated wells 
enabled real time binding measurements of dextran-TR to the FITC- binding of dextran-
TR to the particles are shown in figure 5.3.  Figure 5.3a shows the FRET sensing 
particles prior to their binding reaction with dextran-TR.  When imaged through the 
donor+acceptor channel (λex=470nm, λem>515 nm) the particles emitted green light.   
Figure 5.3b shows a fluorescence image of the same particles following binding of the 
FRET sensing particles to dextran-TR.  The particles emitted orange light since this 
channel allowed both characteristic fluorescence of Fluorescein (green) and Texas Red 
(red) to reach the CCD detector.  Figure 5.3c shows the fluorescence of the same 
particles following binding to dextran-TR taken through the FRET channel (λex =470 nm, 
λem>590nm).  The particles emit red light, which is a clear indication that dextran-TR is 
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indeed bound to the particles. FRET magnitude could be determined based on the 
decrease of the fluorescence of FITC or based on the increase in the fluorescence of 
Texas Red due to FRET between FITC and Texas Red. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
a) 
b) 
Figure 5.3. Digital fluorescence images of FRET sensing particles through the 
donor+acceptor channel (λex=470nm, λem>520nm) in a) the absence of dextran-TR, 
and b) when dextran-TR is bound to the FITC-ConA labeled particles. c) A digital 
fluorescence image of the particles through the FRET channel (λex=470nm, 
λem>590nm) when dextran-TR bound to the FRET sensing particles. 
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In our experiments we found that the determination of the FRET efficiency by measuring 
the decrease in the donor fluorescence was more reproducible than the determination 
of the FRET efficiency based on the increase in acceptor fluorescence.  It should also 
be noted that under our experimental conditions the quenching of the donor 
fluorescence could also result from nonspecific adsorption of dextran-TR on the FRET 
sensing particles.  To minimize non-specific adsorption we blocked the surface of the 
FRET sensing particles with 1mg/ml bovine serum albumin (2 hour incubation) prior to 
adding dextran-TR to the FRET sensing particles solution.   
The dependence of the FRET efficiency between dextran-TR and FITC-ConA on the 
dextran-TR concentration was determined using digital imaging spectroscopy 
measurements.  About 30 FRET sensing particles were imaged through a slit and their 
integrated emission spectra were used to quantify the FRET efficiency.  The temporal 
dependence of the fluorescence spectra of the FRET sensing particles is shown in 
figure 5.4 for dextran-TR concentration of 0.12 µM (λex = 470 nm).  Curve a shows the 
fluorescence spectrum of the FRET sensing particles prior to addition of dextran-TR. 
A single emission peak at 525 nm, characteristic to FITC, is seen.  Curve b shows a 
fluorescence spectrum that was acquired immediately following adding dextran-TR to 
the observed sample.  A slight decrease in the donor fluorescence at 525 nm and a 
slight increase in the acceptor fluorescence at 615 nm are seen, which are 
characteristics of FRET between the donor-acceptor pair.  Curve c shows the 
fluorescence spectrum of the same sample taken 15 minutes following adding dextran-
TR to the sample.  A ~40% decrease in the donor fluorescence and a similar increase in 
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the acceptor fluorescence are seen.  Longer incubation times did not increase the donor 
quenching or acceptor fluorescence significantly.   
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Figure 5.4. Fluorescence spectra of the FRET sensing particles: a) in the absence of 
dextran-TR, b) immediately following the addition of 1.2 µg/ml dextran-TR and c) when 
the FRET between dextran-TR and the FITC-ConA labeled particles reached 
equilibrium (15 min). 
 
 
Figure 5.5 describes the FRET efficiency between dextran-TR and the FITC-ConA 
labeled particles as a function of dextran-TR concentration.  The FRET efficiency was 
defined as Fd/Fd0 where Fd was the donor fluorescence at a given dextran-TR 
concentration and Fd0 was the donor fluorescence in the absence of dextran-TR.  Fd 
was measured at equilibrium 15 minutes following the addition of dextran-TR to the 
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FRET sensing particles solution.  The donor fluorescence at 520 nm decreased by 
about 60% at dextran-TR concentrations higher than 1 µM.  The 15 minutes incubation 
time needed to reach equilibrium was attributed to the relatively slow permeation of 
dextran-TR through the poly-lysine membrane.  This enabled us to conclude with high 
degree of confidence that the observed signal changes resulted from FRET between 
dextran-TR and FITC-ConA labeled particles.  Other possible interfering optical effects 
like inner filter effects would result in instant signal changes since they would not 
depend on the permeation of dextran-TR through the polylysine membrane or on the 
chemical reaction between dextran-TR and FITC-ConA labeled particles. 
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Figure 5.5. The FRET signal between dextran-TR and FITC-ConA coated particles as a 
function of dextran-TR concentration.  The FRET magnitude was determined by 
following the decrease in the donor fluorescence.  The fluorescence intensity of the 
particles (Fd) was measured through donor cube [λex=470nm, 520nm<λem<560nm) 
and was normalized to the initial donor fluorescence (Fd0).  
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5.3.5. Determination of Binding Constant of Dextran-TR 
The binding constant of dextran-TR to the FRET sensing particles was calculated using 
the following expression [195]:  
aKF
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−     (5.1) 
 
where is the initial intensity of the FRET sensing particles [prior to adding dextran-
TR), is the maximum donor quenching obtained at saturation, ∆ = , F is 
donor fluorescence after adding dextran-TR, 
0F
maxF F FF −0
maxF∆ = max0 FF − and is the binding 
constant in M
aK
-1. The apparent binding constant calculated using the equation 5.1does 
not give any information about the cooperativity of the binding interaction between 
dextran-TR and the FRET sensing particles. Figure 5.6 describes the product of the 
concentration of dextran-TR and F0/∆F as a function of the product of the concentration 
of dextran-TR and F0/∆Fmax. 
The binding constant Ka is calculated from the intercept of this plot to be 1.1x107M-1.  As 
expected, this Ka value is an order of magnitude larger than Ka value reported earlier by 
Borrebaeck et al for the binding of lower molecular weight dextran to ConA-coated 
sepharose particles [194]. 
 
 105
0.0 0.5 1.0 1.5 2.0 2.5
0.0
0.5
1.0
1.5
2.0
2.5
  
[D
ex
tra
n-
TR
,µ
 M
] F
0/
 ∆
 F
[Dextran-TR, µM]F0/ ∆Fmax
 
Figure 5.6. Determination of the apparent association constant between  
dextran-TR and FRET sensing particles based on the equation [5.1]. 
 
 
5.3.6. FRET Inhibition Assays 
Following the dextran-TR binding studies we developed binding inhibition assays based 
on decreasing the binding efficiency between dextran-TR and the FITC ConA-labeled 
particles in the presence of carbohydrates or glycoproteins.  First, a multi well 
chambered coverglass was coated with FRET sensing particles as previously 
described.  Then, monomeric carbohydrate or glycoprotein solutions of various 
concentrations were added to the wells for a 1 hour incubation period at room 
temperature. Aliquots of 4µl 60 µg/ml Dextran-TR were then added to the wells. 
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A washing step to remove unbound inhibitor molecules was not required.  It was 
expected that inhibitors with high affinity to ConA would cluster the lectin receptors.  
Dextran-TR would compete poorly on the ConA binding sites, which would result in low 
FRET efficiency between dextran-TR and the FRET sensing particles.  In contrast, we 
expected that inhibitors with low affinity to ConA would be easily displaced by the 
dextran-TR molecules.  This would result in high FRET efficiency between dextran-TR 
and the FITC-ConA labeled particles, which would be similar to the one obtained in the 
absence of inhibitor.  The inhibition percentage was calculated as follows: 
 
In% = [(Fi  Fni) / ∆F] x 100          (5.2) 
 
In% is the percent inhibition, Fi is the fluorescence intensity of the particles 15 minutes 
following the addition of dextran-TR in the presence of inhibitor, and Fni is the 
fluorescence intensity of the particles 15 minutes following the addition of dextran-TR in 
the absence of inhibitor.  ∆F is defined as: 
∆F = FIn100%  Fni         (5.3) 
 
FIn100% is the fluorescence intensity of the particles at 100% inhibition.  It should be 
noted that the FRET inhibitors were quite effective with FRET inhibition larger than 90% 
at high inhibitor concentrations.  IC50 values were defined as the concentrations of 
inhibitors required to decrease the FRET efficiency between dextran-TR and the FITC-
ConA labeled particles by 50%. 
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Figure 5.7 summarizes the inhibition efficiency of monomeric carbohydrates and 
glycoproteins of the binding between dextran-TR and the FRET sensing particles. 
Galactose appears to be the worst performing inhibitor, which is attributed to the weak 
affinity between ConA and Galactose.  As expected, the inhibition efficiency of Mannose 
is higher than that of Galactose.  However, Mannose as well is characterized with a 
relatively high IC50 of 1.7 mM.  It is possible that the large number of glucose residues in 
dextran-TR (MW =10000 Da), enhances its binding affinity to the FRET sensing 
particles through multivalent interactions.  The mechanism of multivalent interactions 
between the dextran-TR and ConA is complex and still not completely understood [184, 
186]. Chelate effects, subsite bindings, steric stabilization and receptor clustering could 
contribute to the increased affinity of dextran-TR for the FRET sensing particles [186}. 
As a result, high concentrations of monomeric carbohydrates like Mannose are required 
to effectively block the binding between dextran-TR and the FRET sensing particles.   
Glycoproteins, which contain a large number of glycosylic residues, have lower IC50 
values.  For example, Glucose oxidase was found to be the most potent inhibitor with an 
IC50 value of 0.5 µM.  Ovalbumine, a glycoprotein, which is not as rich in glycosylic 
residues showed an IC50 value of about 4.5 µM. Avidin, another glycoprotein, which has 
only four Mannose residues, had the smallest inhibition efficiency among the screened 
glycoproteins with an IC50 of 75µM.   
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Figure 5.7 The inhibition of dextran-TR binding to FITC-ConA labeled particles by 
Galactose, Mannose, Avidin, Ovalbumin and Glucoseoxidase. The error bars were 
obtained from three analyses of fields containing about 100 particles.  
 
 
5.4. Summary and Conclusions 
Micrometric FRET sensing particles were prepared by labeling polystyrene particles 
with FITC-ConA.   The particles were characterized for their fluorescence intensity, 
photostability and chemical stability under storage conditions.  Following extensive 
optimization studies bright and stable FITC-ConA labeled particles were formed.  The 
performance limiting factor of the FITC-ConA labeled was the bioactivity of ConA.  In 
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solution the FITC-ConA labeled particles retained their carbohydrate binding activity for 
up to 5 days.  This degradation in their binding activity was attributed to bacterial growth 
that is known to affect lectin activity [76,184].  Dextran-TR molecules bound selectively 
to the FITC-ConA labeled particles and under our experimental conditions the reaction 
took about 15 minutes to reach equilibrium.  FRET between dextran-TR and FITC 
ConA-coated particles resulted in a fluorescence decrease of FITC by about 50% and a 
similar increase in the fluorescence of Texas Red.  The FRET sensing particles were 
applied to evaluate the inhibition efficiency of monomeric carbohydrates and 
glycoproteins of the binding between dextran-TR and the FITC-ConA labeled particles.  
The FRET sensing particles discriminated between monomeric carbohydrates like 
Mannose and Galactose.  However, millimolar level of inhibitors was required to 
effectively inhibit the FRET between dextran-TR and the FITC-ConA labeled particles.  
This was attributed to the large number of glycosylic residues in dextran (MW 10000 
Da).  Glycoproteins that contain a larger number of glycosylic residues exhibited higher 
inhibition efficiency.  For example the IC50 value of Glucose oxidase was as low as 0.5 
µM.  The FRET sensing particles technology could be used to screen other groups of 
carbohydrates or glycoproteins by changing ConA with other lectins.  Currently we are 
exploring the possibility of using the FRET sensing particles as the building blocks of 
FRET sensing arrays that will be designed for high throughput screening of 
carbohydrate and glycoprotein based drugs.   
 
 110
CHAPTER 6 
DISCUSSION 
 
 
Fluorescence resonance energy transfer (FRET) is a unique phenomenon that 
combines the sensitivity and selectivity of fluorescence with the strong dependence of 
FRET on the distance between donor and acceptor molecules. Combined with a variety 
of novel indicators and computational methods, FRET microscopy has been widely 
used in studying protein-protein interactions, protein folding, membrane topology and 
DNA hybridization in single cells. Using FRET and a biological sensing element enabled 
the expansion of fluorescence sensors other analytes inaccessible to fluorescence 
sensors.  
 
Chapter 3 describes a novel method based on FRET to monitor and quantify delivery of 
fluorophores into cells. For the first time FRET was utilized to confirm whether 
fluorophores truly penetrated the cellular membrane or they were only absorbed on the 
cell membrane. While limited in quantitative power, FRET between delivered donor 
molecules and acceptor labeled cells could be used to confirm the delivery of donor 
fluorescent molecules into cells. The use of the acceptor permeation into donor labeled 
macrophages was easier and less prone to errors. Using donor labeled cells it was 
possible to determine whether acceptor molecules were entrapped in the endosomes or 
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delivered to the cellular cytoplasm. However, a relatively high acceptor concentration in 
micromolar level was still needed to obtain measurable FRET signals in a 3-D system 
like the cellular milieu. These results demonstrated the necessity to reduce the 
dimensionality of FRET systems in order to increase FRET efficiency between donor 
and acceptor molecules. The next research project was directed toward the 
development and application of particle based FRET sensors to increase the sensitivity 
of the technique.  
 
Chapter 4 describes the synthesis and analytical properties of FRET sensing lipobeads. 
In lipobeads, the donor fluorophores were located on the surface of the phospholipid 
membrane that coated the sensor surface. The interaction of fluorophores with the 
phospholipid membranes was evaluated by FRET measurements between donor 
labeled lipobeads and acceptor molecules. The FRET efficiency between acceptor 
molecules and the donor labeled lipobeads was found to be approximately 3-fold higher 
than FRET efficiency between the same donor and acceptor molecules when dissolved 
in solution.  We concluded that the change in the dimensionality of the system in which 
FRET occurred improved the sensitivity of our measurements. However, the 
improvement was smaller than expected due to significant contributions from inner filter 
effects. We then decided to design FRET sensing lipobeads that contain biorecognition 
elements in order to increase the affinity of acceptor molecules to the lipobeads thus 
reducing the concentration of acceptor molecules required for efficient FRET.  
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Chapter 5 focuses on the development of FRET sensing beads for non-fluorescent 
carbohydrates and glycoproteins.  Micrometric FRET sensing particles were prepared 
by labeling polystyrene particles with FITC-ConA (FITC- Concanavalin A).  The 
fluorescence recovery of the donor fluorescence intensity due to competitive binding of 
sugar derivatives to microspheres labeled with FITC-ConA in the presence of dextran-
Texas Red provided the basis for the new developed particle-based FRET sensors. The 
particle-based FRET sensors were stable and showed no fluorophore leakage up to five 
days. The performance limiting factor of the FRET sensing particles was the bioactivity 
of ConA. The FRET sensing particles were applied to quantitatively determine the 
inhibition efficiency of monomeric carbohydrates and glycoproteins of the binding 
between dextran-TR and the FITC-ConA labeled particles.  The particle-based FRET 
sensors discriminated between monomeric carbohydrates like mannose and galactose.  
The inhibition potency was evaluated as the inhibitor concentrations needed to realize 
50 % inhibition of FRET between dextran-TR and the FITC-ConA coated beads. The 
newly developed FRET sensing particles could be used as the building blocks of FRET 
sensing arrays designed for high throughput screening of carbohydrate and glycoprotein 
based drugs.   
 
Several intrinsic limiting factors affected the quantitative power of the newly developed 
particle-based FRET sensors. First, the relation between the calibration curves obtained 
in solutions and an intracellular analyte levels is unclear. Fortunately, this uncertainty in 
our experiments did not affect the interpretation of kinetics data, which was the main 
interest of our studies. For our cellular studies, the inability to recognize sub-population 
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of cells also increased the error in the measurements. The murine macrophages were a 
heterogeneous mixture of old and young cells, which contributed up to 30% variation in 
between fluorescence response of individual cells.  In future studies the selection of cell 
subpopulations will enhance the precision of FRET measurements in cells.  
 
In the case of the FRET sensing lipobeads the sensitivity of FRET measurements 
efficiency was affected by significant contributions from inner filter effects.  Future 
experiments with FRET sensing lipobeads should correct for these errors.  Recently, the 
covalent attachment of the phospholipid membrane and the fluorophores to the 
microsphere surface carried out in our laboratory increased the stability of lipobead-
based sensors. The covalent binding of the donor and acceptor molecules on this type 
of particles will provide the opportunity to evaluate the interaction of non-fluorescent 
drugs with supported phospholipid membranes while minimizing inner filter effects. It is 
also important to develop better data processing techniques since the large number of 
observed particles generate large amount of data that complicate the analysis. Another 
important factor that affected the precision of the developed FRET sensors has been 
the ~5% fluctuation of the microscope light source. Replacement of the mercury lamp 
with a laser source could improve the precision of FRET measurements. The overlap 
between the donor and acceptor emission spectra given by the low resolution of the 
used gratings limited the selection of other donor and acceptor pairs. A spectrograph 
and higher resolution gratings were recently installed in our laboratory enable the use of 
other donor and acceptor pairs to obtain higher FRET efficiency. The activity of FITC-
ConA lectin and the number of donor molecules per protein were other important factors 
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that affected our measurements. A controlled synthesis of the donor labeled 
Concanavalin A, replacing the FITC label with a more stable fluorescent probe would be 
desirable. The inherent instability problems of lectins could be overcome by substituting 
them with boronic acids that bind selectively to saccharide. Application of the FRET 
based sensors in intracellular analysis is limited to macrophage cells in which the 
sensors are engulfed through phagocytotic events. A novel approach for the delivery of 
the FRET sensing beads is necessary for other type of cells. The incorporation of newly 
discovered cell penetrating peptides on the sensor surface could allow future FRET 
based sensors to measure important cellular constituents, confirm drug and gene 
delivery into cells and provide important insights on cellular signaling mechanisms. 
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